category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology
GO:0005488,5.486112684609773e-86,1,984,14904,binding,MF
GO:0003674,2.0813260376389436e-85,1,1068,17267,molecular_function,MF
GO:0005622,8.986948450782954e-80,1,958,14622,intracellular,CC
GO:0044424,6.545969692529529e-79,1,956,14612,intracellular part,CC
GO:0008150,1.8440600362853693e-76,1,1062,17874,biological_process,BP
GO:0005737,1.8816744710632757e-74,1,819,11401,cytoplasm,CC
GO:0044464,1.3071710704109342e-69,1,1023,16770,cell part,CC
GO:0005575,1.3373019736341933e-69,1,1083,18853,cellular_component,CC
GO:0005515,2.0422717022183472e-69,1,818,11611,protein binding,MF
GO:0009987,4.529260448245669e-69,1,995,16356,cellular process,BP
GO:0005623,5.489043493828609e-69,1,1024,16837,cell,CC
GO:0043226,1.142938368951874e-65,1,891,13675,organelle,CC
GO:0044444,3.0925379383104697e-62,1,705,9556,cytoplasmic part,CC
GO:0044446,5.1459957465022975e-61,1,688,9455,intracellular organelle part,CC
GO:0043229,6.717059932006926e-61,1,846,12865,intracellular organelle,CC
GO:0044422,1.5781517689545707e-60,1,702,9755,organelle part,CC
GO:0043227,6.507919421975106e-60,1,834,12663,membrane-bounded organelle,CC
GO:0043231,5.403712517651988e-54,1,753,11174,intracellular membrane-bounded organelle,CC
GO:0065007,2.8451393238737576e-48,1,797,12454,biological regulation,BP
GO:0071840,5.938114775383639e-46,1,511,6533,cellular component organization or biogenesis,BP
GO:0005829,2.0737671053683417e-45,1,423,4979,cytosol,CC
GO:0050789,1.7803286195477773e-44,1,756,11774,regulation of biological process,BP
GO:0016043,1.6448867936785198e-43,1,495,6349,cellular component organization,BP
GO:0031974,1.7415016909323715e-42,1,439,5585,membrane-enclosed lumen,CC
GO:0043233,1.7415016909323715e-42,1,439,5585,organelle lumen,CC
GO:0070013,1.7415016909323715e-42,1,439,5585,intracellular organelle lumen,CC
GO:0044237,1.2959534953668104e-41,1,711,11021,cellular metabolic process,BP
GO:0008152,1.2336091776654477e-40,1,747,12108,metabolic process,BP
GO:0071704,1.9717259906693856e-40,1,726,11652,organic substance metabolic process,BP
GO:0044238,6.683277213350928e-40,1,701,10906,primary metabolic process,BP
GO:0097159,1.9519740133043728e-39,1,471,6183,organic cyclic compound binding,MF
GO:1901363,2.3845317110017772e-39,1,466,6096,heterocyclic compound binding,MF
GO:0005634,1.1450405820602354e-37,1,539,7675,nucleus,CC
GO:0031981,1.3946946858702116e-37,1,362,4441,nuclear lumen,CC
GO:0006807,4.604959565021489e-37,1,670,10430,nitrogen compound metabolic process,BP
GO:0050794,1.1328796000486012e-36,1,695,10751,regulation of cellular process,BP
GO:0043232,1.4051321207395307e-36,1,364,4523,intracellular non-membrane-bounded organelle,CC
GO:0043228,2.244308930744566e-36,1,364,4532,non-membrane-bounded organelle,CC
GO:0044428,2.4421189788589125e-36,1,381,4832,nuclear part,CC
GO:0050896,2.1536739881338483e-35,1,604,8945,response to stimulus,BP
GO:0043170,3.0227120097623676e-33,1,631,10092,macromolecule metabolic process,BP
GO:0044260,5.798596345977335e-31,1,556,8259,cellular macromolecule metabolic process,BP
GO:0051716,6.480080782590664e-31,1,514,7413,cellular response to stimulus,BP
GO:0005654,1.4844252802925486e-30,1,299,3497,nucleoplasm,CC
GO:0003723,6.788572358953465e-30,1,184,1871,RNA binding,MF
GO:0006950,1.3914181849282456e-29,1,320,3946,response to stress,BP
GO:0006996,2.1397000946462635e-29,1,315,3841,organelle organization,BP
GO:0032991,1.202147293313772e-28,1,400,5711,protein-containing complex,CC
GO:0048518,1.3425440251461195e-28,1,436,6062,positive regulation of biological process,BP
GO:1901564,6.914337267770727e-28,1,472,6867,organonitrogen compound metabolic process,BP
GO:0010033,2.4837168435098646e-27,1,275,3250,response to organic substance,BP
GO:0043167,4.853314244885511e-27,1,442,6155,ion binding,MF
GO:0048522,6.644804065321132e-27,1,393,5357,positive regulation of cellular process,BP
GO:0031982,1.4133074314519384e-26,1,304,3803,vesicle,CC
GO:0051179,2.2915808308676613e-26,1,453,6561,localization,BP
GO:0016020,3.286201291948508e-26,1,587,9115,membrane,CC
GO:0051128,5.623264572041213e-26,1,225,2480,regulation of cellular component organization,BP
GO:0034641,7.44921126959458e-26,1,459,6904,cellular nitrogen compound metabolic process,BP
GO:0003676,3.558017716455164e-25,1,319,4222,nucleic acid binding,MF
GO:0019222,4.850703905623593e-25,1,466,7104,regulation of metabolic process,BP
GO:0048519,2.3912703323069647e-24,1,391,5747,negative regulation of biological process,BP
GO:1901360,4.908327097343488e-24,1,439,6595,organic cyclic compound metabolic process,BP
GO:0006139,7.875288633376655e-24,1,416,6167,nucleobase-containing compound metabolic process,BP
GO:0006810,1.81275509818123e-23,1,364,5041,transport,BP
GO:0006725,2.3279170386767176e-23,1,425,6371,cellular aromatic compound metabolic process,BP
GO:0023052,3.153252104756712e-23,1,439,6429,signaling,BP
GO:0019538,4.21194136340415e-23,1,402,5834,protein metabolic process,BP
GO:0007154,7.184945593276872e-23,1,439,6456,cell communication,BP
GO:0032502,7.50636235704482e-23,1,428,6258,developmental process,BP
GO:0043230,1.04940101205441e-22,1,192,2135,extracellular organelle,CC
GO:0051234,1.0623895518691607e-22,1,368,5165,establishment of localization,BP
GO:0010646,1.1744829713323802e-22,1,278,3514,regulation of cell communication,BP
GO:0046483,1.2398257713985048e-22,1,420,6326,heterocycle metabolic process,BP
GO:0048583,1.721322269802548e-22,1,314,4181,regulation of response to stimulus,BP
GO:0023051,4.22123286653782e-22,1,279,3563,regulation of signaling,BP
GO:1903561,4.460308699831867e-22,1,190,2130,extracellular vesicle,CC
GO:0070062,7.412539578877069e-22,1,188,2107,extracellular exosome,CC
GO:0080090,1.0586391756070141e-21,1,415,6097,regulation of primary metabolic process,BP
GO:0044267,1.0987252321635619e-21,1,365,5230,cellular protein metabolic process,BP
GO:0031323,1.3433307379970008e-21,1,421,6228,regulation of cellular metabolic process,BP
GO:0048856,1.3981353186413866e-21,1,402,5844,anatomical structure development,BP
GO:0048523,1.451989433303124e-21,1,344,4831,negative regulation of cellular process,BP
GO:0048731,2.0435749542599448e-21,1,345,4784,system development,BP
GO:0044085,2.3253730850247822e-21,1,258,3274,cellular component biogenesis,BP
GO:0060255,2.7532238478078344e-21,1,426,6593,regulation of macromolecule metabolic process,BP
GO:0090304,6.207327851118743e-21,1,372,5512,nucleic acid metabolic process,BP
GO:0036094,6.247666037901441e-21,1,214,2481,small molecule binding,MF
GO:0000166,7.205052664024588e-21,1,191,2107,nucleotide binding,MF
GO:1901265,7.550665509393734e-21,1,191,2108,nucleoside phosphate binding,MF
GO:0044421,8.943348032773121e-21,1,264,3555,extracellular region part,CC
GO:0071310,1.3703551954357305e-20,1,221,2671,cellular response to organic substance,BP
GO:0003824,1.3922033886396877e-20,1,388,5656,catalytic activity,MF
GO:1901575,1.900434345451536e-20,1,190,2168,organic substance catabolic process,BP
GO:0043168,2.098034879723879e-20,1,229,2749,anion binding,MF
GO:0007165,2.4086798563786196e-20,1,403,5964,signal transduction,BP
GO:0002376,2.6131262721066618e-20,1,233,2893,immune system process,BP
GO:0007275,3.008175470275526e-20,1,371,5350,multicellular organism development,BP
GO:0009058,3.669243103032521e-20,1,416,6259,biosynthetic process,BP
GO:0051171,3.763117697074123e-20,1,400,5926,regulation of nitrogen compound metabolic process,BP
GO:0005615,4.1081572928759754e-20,1,250,3355,extracellular space,CC
GO:0044271,5.602675241233485e-20,1,347,4953,cellular nitrogen compound biosynthetic process,BP
GO:1901576,6.872229955837655e-20,1,411,6182,organic substance biosynthetic process,BP
GO:0012505,7.482637963323883e-20,1,318,4399,endomembrane system,CC
GO:0044249,7.550397743550971e-20,1,406,6090,cellular biosynthetic process,BP
GO:0065008,1.7989868473582568e-19,1,296,4023,regulation of biological quality,BP
GO:0033554,1.8757846192593417e-19,1,180,2055,cellular response to stress,BP
GO:0051239,4.244347936851301e-19,1,247,3213,regulation of multicellular organismal process,BP
GO:0042221,4.48813298723974e-19,1,331,4716,response to chemical,BP
GO:0048869,7.225688475960914e-19,1,311,4305,cellular developmental process,BP
GO:0070887,7.891759246090718e-19,1,248,3240,cellular response to chemical stimulus,BP
GO:0051704,8.582035212688954e-19,1,208,2552,multi-organism process,BP
GO:0097367,8.93892770965936e-19,1,191,2200,carbohydrate derivative binding,MF
GO:0009056,1.0557366195677568e-18,1,211,2607,catabolic process,BP
GO:0009893,1.5851338052768266e-18,1,269,3589,positive regulation of metabolic process,BP
GO:0033036,3.900874260864118e-18,1,237,3096,macromolecule localization,BP
GO:0032501,4.04801566251683e-18,1,475,7562,multicellular organismal process,BP
GO:0030154,4.318546994028935e-18,1,298,4113,cell differentiation,BP
GO:0009057,5.5773889220668835e-18,1,134,1390,macromolecule catabolic process,BP
GO:0022607,9.7925315714119e-18,1,233,3036,cellular component assembly,BP
GO:0009966,9.862698275425582e-18,1,240,3144,regulation of signal transduction,BP
GO:0010604,1.3388311337653818e-17,1,251,3319,positive regulation of macromolecule metabolic process,BP
GO:0010467,2.333609108561344e-17,1,380,6236,gene expression,BP
GO:0016070,2.3629740117224868e-17,1,331,4989,RNA metabolic process,BP
GO:0035556,2.48319848542512e-17,1,227,2928,intracellular signal transduction,BP
GO:0006952,2.973895669719573e-17,1,148,1656,defense response,BP
GO:0005576,3.109346500481232e-17,1,295,4356,extracellular region,CC
GO:0044403,3.3648640455572375e-17,1,97,880,symbiont process,BP
GO:0034097,6.022893951070014e-17,1,118,1182,response to cytokine,BP
GO:0050793,6.488863020066248e-17,1,208,2660,regulation of developmental process,BP
GO:0006955,9.870270825050018e-17,1,168,1990,immune response,BP
GO:0031325,1.2783141481401514e-16,1,246,3287,positive regulation of cellular metabolic process,BP
GO:0016032,1.551933397950723e-16,1,92,829,viral process,BP
GO:0035639,2.20164652556881e-16,1,159,1796,purine ribonucleoside triphosphate binding,MF
GO:0044419,2.5577477015121294e-16,1,98,928,interspecies interaction between organisms,BP
GO:0051246,2.825232465220206e-16,1,216,2849,regulation of protein metabolic process,BP
GO:0065009,2.918522101810775e-16,1,225,2963,regulation of molecular function,BP
GO:0065003,3.921537878905423e-16,1,160,1900,protein-containing complex assembly,BP
GO:0051173,3.932965025185086e-16,1,237,3157,positive regulation of nitrogen compound metabolic process,BP
GO:0034645,4.861157320377258e-16,1,329,4891,cellular macromolecule biosynthetic process,BP
GO:0051649,6.1567389494025285e-16,1,180,2226,establishment of localization in cell,BP
GO:0042802,6.184079251317825e-16,1,150,1715,identical protein binding,MF
GO:0016192,8.421999647806918e-16,1,167,1996,vesicle-mediated transport,BP
GO:0034341,9.112288907327798e-16,1,38,181,response to interferon-gamma,BP
GO:0032553,1.1480926614262195e-15,1,162,1877,ribonucleotide binding,MF
GO:0044265,1.4140122818004382e-15,1,112,1156,cellular macromolecule catabolic process,BP
GO:0007166,1.6577855466501352e-15,1,220,2906,cell surface receptor signaling pathway,BP
GO:0043933,1.879825751342129e-15,1,177,2218,protein-containing complex subunit organization,BP
GO:0010468,2.0227498677234098e-15,1,316,4942,regulation of gene expression,BP
GO:0017076,2.1579256358754064e-15,1,161,1874,purine nucleotide binding,MF
GO:0032555,2.5026517470959346e-15,1,160,1861,purine ribonucleotide binding,MF
GO:0044248,2.5874004541979806e-15,1,183,2316,cellular catabolic process,BP
GO:0051641,2.801455712424024e-15,1,217,2905,cellular localization,BP
GO:0032879,2.9096543970937775e-15,1,211,2812,regulation of localization,BP
GO:0009653,3.1198365471748292e-15,1,207,2708,anatomical structure morphogenesis,BP
GO:0009059,4.09832637447849e-15,1,333,5044,macromolecule biosynthetic process,BP
GO:0009605,4.1045148986408866e-15,1,188,2405,response to external stimulus,BP
GO:0048513,5.517423968102269e-15,1,250,3463,animal organ development,BP
GO:0044093,6.062711873831793e-15,1,151,1763,positive regulation of molecular function,BP
GO:0019899,7.520706191401896e-15,1,177,2206,enzyme binding,MF
GO:1901362,1.0008715139422373e-14,1,302,4436,organic cyclic compound biosynthetic process,BP
GO:0034654,1.2757072863476197e-14,1,290,4214,nucleobase-containing compound biosynthetic process,BP
GO:1901700,1.6488414294918438e-14,1,140,1622,response to oxygen-containing compound,BP
GO:0045087,1.6538873440575852e-14,1,93,910,innate immune response,BP
GO:0009892,1.916699076763462e-14,1,229,3451,negative regulation of metabolic process,BP
GO:0019438,1.9998817446737123e-14,1,293,4287,aromatic compound biosynthetic process,BP
GO:0018130,2.6279220732541125e-14,1,292,4277,heterocycle biosynthetic process,BP
GO:2000026,3.2823464115670896e-14,1,168,2126,regulation of multicellular organismal development,BP
GO:0005856,3.3916530543063606e-14,1,169,2092,cytoskeleton,CC
GO:0008219,3.441634120744749e-14,1,175,2232,cell death,BP
GO:0034655,4.400687822362492e-14,1,73,647,nucleobase-containing compound catabolic process,BP
GO:0009889,4.4550746722619474e-14,1,292,4339,regulation of biosynthetic process,BP
GO:0051707,4.958248316334469e-14,1,94,941,response to other organism,BP
GO:0046907,5.1270869424278046e-14,1,150,1833,intracellular transport,BP
GO:0043207,5.591546534155979e-14,1,94,943,response to external biotic stimulus,BP
GO:0010605,5.749286145721246e-14,1,214,3216,negative regulation of macromolecule metabolic process,BP
GO:0005730,6.616837929462995e-14,1,105,1293,nucleolus,CC
GO:0071345,8.95547270970144e-14,1,104,1093,cellular response to cytokine stimulus,BP
GO:0051130,9.021705174092062e-14,1,115,1251,positive regulation of cellular component organization,BP
GO:0032268,1.0891964479907785e-13,1,196,2653,regulation of cellular protein metabolic process,BP
GO:0051049,1.172393815666902e-13,1,152,1860,regulation of transport,BP
GO:0010628,1.3960203480206084e-13,1,160,1974,positive regulation of gene expression,BP
GO:0019904,1.6394236621473768e-13,1,78,704,protein domain specific binding,MF
GO:0009607,1.7858891072685013e-13,1,95,975,response to biotic stimulus,BP
GO:0033043,1.8380513283735234e-13,1,113,1240,regulation of organelle organization,BP
GO:0045595,2.0923478758673087e-13,1,151,1856,regulation of cell differentiation,BP
GO:0061024,2.149121088025885e-13,1,85,818,membrane organization,BP
GO:0046700,2.3106832254050884e-13,1,75,694,heterocycle catabolic process,BP
GO:0009894,2.684613605058601e-13,1,95,975,regulation of catabolic process,BP
GO:0008283,2.7372039697920446e-13,1,156,1984,cell proliferation,BP
GO:0045296,3.1744936947483323e-13,1,48,330,cadherin binding,MF
GO:0009719,3.230344940406078e-13,1,138,1644,response to endogenous stimulus,BP
GO:0008104,3.334204344032859e-13,1,200,2746,protein localization,BP
GO:0019219,3.7272364355987264e-13,1,277,4082,regulation of nucleobase-containing compound metabolic process,BP
GO:1901361,4.228714714753549e-13,1,78,744,organic cyclic compound catabolic process,BP
GO:0007049,4.424389240981964e-13,1,148,1843,cell cycle,BP
GO:0007010,5.536506959604979e-13,1,118,1321,cytoskeleton organization,BP
GO:0031326,5.95529274139267e-13,1,283,4262,regulation of cellular biosynthetic process,BP
GO:0071702,6.777732327263138e-13,1,200,2773,organic substance transport,BP
GO:0044270,6.832043447566854e-13,1,74,695,cellular nitrogen compound catabolic process,BP
GO:0019439,7.520504956800683e-13,1,75,711,aromatic compound catabolic process,BP
GO:0060333,7.711946213844693e-13,1,22,73,interferon-gamma-mediated signaling pathway,BP
GO:0031410,7.99508333138111e-13,1,174,2285,cytoplasmic vesicle,CC
GO:0016071,8.029727564484982e-13,1,84,843,mRNA metabolic process,BP
GO:0097708,8.835934343011218e-13,1,174,2288,intracellular vesicle,CC
GO:0031324,9.688567268942417e-13,1,190,2606,negative regulation of cellular metabolic process,BP
GO:0071346,1.0705940281105463e-12,1,32,162,cellular response to interferon-gamma,BP
GO:2000112,1.2976633235891034e-12,1,265,3939,regulation of cellular macromolecule biosynthetic process,BP
GO:0006401,1.3519927587440699e-12,1,51,397,RNA catabolic process,BP
GO:0044445,1.4423156168790848e-12,1,38,242,cytosolic part,CC
GO:0045935,1.4607471394464236e-12,1,151,1867,positive regulation of nucleobase-containing compound metabolic process,BP
GO:0014070,1.5236592514358344e-12,1,90,907,response to organic cyclic compound,BP
GO:0051252,1.5558893588453648e-12,1,258,3768,regulation of RNA metabolic process,BP
GO:0051172,1.6060407393484976e-12,1,180,2444,negative regulation of nitrogen compound metabolic process,BP
GO:0034340,1.676613851914889e-12,1,24,92,response to type I interferon,BP
GO:1990904,2.507724281806792e-12,1,98,1368,ribonucleoprotein complex,CC
GO:0006915,2.531020419467474e-12,1,153,1963,apoptotic process,BP
GO:0048584,2.7583960126358294e-12,1,176,2358,positive regulation of response to stimulus,BP
GO:0012501,2.805210070457559e-12,1,161,2103,programmed cell death,BP
GO:0043603,2.8402412543458518e-12,1,99,1138,cellular amide metabolic process,BP
GO:0051240,3.4364003654761146e-12,1,142,1788,positive regulation of multicellular organismal process,BP
GO:0043412,3.685066573971473e-12,1,283,4341,macromolecule modification,BP
GO:0005925,3.728235873262028e-12,1,52,405,focal adhesion,CC
GO:0010556,3.92993943375073e-12,1,270,4078,regulation of macromolecule biosynthetic process,BP
GO:0016787,4.016364132755355e-12,1,185,2507,hydrolase activity,MF
GO:0033993,4.189347716335734e-12,1,89,919,response to lipid,BP
GO:0005912,4.3158723540817046e-12,1,63,546,adherens junction,CC
GO:0009891,4.571593932461407e-12,1,156,1988,positive regulation of biosynthetic process,BP
GO:0005924,4.968383946111616e-12,1,52,408,cell-substrate adherens junction,CC
GO:0031328,5.192886256240794e-12,1,154,1957,positive regulation of cellular biosynthetic process,BP
GO:0045862,5.291220458004765e-12,1,48,361,positive regulation of proteolysis,BP
GO:0006793,5.698224320519179e-12,1,227,3310,phosphorus metabolic process,BP
GO:1902531,5.884180688976488e-12,1,151,1947,regulation of intracellular signal transduction,BP
GO:0070161,6.18595550439856e-12,1,64,562,anchoring junction,CC
GO:0006464,6.501779691074784e-12,1,271,4131,cellular protein modification process,BP
GO:0036211,6.501779691074784e-12,1,271,4131,protein modification process,BP
GO:0006796,7.68678823496221e-12,1,225,3283,phosphate-containing compound metabolic process,BP
GO:0045184,7.690530195346263e-12,1,158,2097,establishment of protein localization,BP
GO:0030055,7.704831202418925e-12,1,52,412,cell-substrate junction,CC
GO:0006402,7.763154743352715e-12,1,47,364,mRNA catabolic process,BP
GO:0034622,8.378104378265655e-12,1,98,1109,cellular protein-containing complex assembly,BP
GO:0046872,1.0874712679549603e-11,1,275,4145,metal ion binding,MF
GO:0071944,1.1722234057630747e-11,1,344,5428,cell periphery,CC
GO:0050790,1.2108866525073777e-11,1,171,2316,regulation of catalytic activity,BP
GO:0030162,1.2287470885517136e-11,1,76,763,regulation of proteolysis,BP
GO:0010647,1.2815632266517404e-11,1,144,1835,positive regulation of cell communication,BP
GO:0034613,1.3654133631466775e-11,1,144,1862,cellular protein localization,BP
GO:0010629,1.680026652898915e-11,1,156,2354,negative regulation of gene expression,BP
GO:0044433,1.7339373356642315e-11,1,122,1477,cytoplasmic vesicle part,CC
GO:0005886,1.9214161530928705e-11,1,337,5309,plasma membrane,CC
GO:0008144,1.9310344245099823e-11,1,138,1710,drug binding,MF
GO:0070727,2.0731826198182274e-11,1,144,1873,cellular macromolecule localization,BP
GO:0044877,2.108650197765059e-11,1,99,1107,protein-containing complex binding,MF
GO:0043169,2.4183938212091645e-11,1,278,4234,cation binding,MF
GO:0010942,2.5145631547096827e-11,1,72,720,positive regulation of cell death,BP
GO:0043067,2.850448987666254e-11,1,127,1590,regulation of programmed cell death,BP
GO:0022008,3.0456034081735896e-11,1,132,1614,neurogenesis,BP
GO:0051276,3.200035578005167e-11,1,104,1212,chromosome organization,BP
GO:0023056,3.211050498084552e-11,1,143,1842,positive regulation of signaling,BP
GO:0060337,3.319837137933599e-11,1,22,88,type I interferon signaling pathway,BP
GO:0071357,3.319837137933599e-11,1,22,88,cellular response to type I interferon,BP
GO:0008092,3.355471264831658e-11,1,91,973,cytoskeletal protein binding,MF
GO:0043065,3.8856106556717073e-11,1,68,664,positive regulation of apoptotic process,BP
GO:0010557,3.8866548475613234e-11,1,145,1848,positive regulation of macromolecule biosynthetic process,BP
GO:0010941,5.325769402109178e-11,1,133,1709,regulation of cell death,BP
GO:0031090,5.5936589018725254e-11,1,198,2853,organelle membrane,CC
GO:0045202,5.693135385518996e-11,1,104,1169,synapse,CC
GO:0043068,5.7943345967321824e-11,1,68,672,positive regulation of programmed cell death,BP
GO:0050839,6.594363580559253e-11,1,57,498,cell adhesion molecule binding,MF
GO:0098805,6.759642805401091e-11,1,130,1637,whole membrane,CC
GO:0051254,7.149745744001743e-11,1,134,1676,positive regulation of RNA metabolic process,BP
GO:0051094,7.56672315993816e-11,1,115,1404,positive regulation of developmental process,BP
GO:0022603,7.574751907550569e-11,1,97,1138,regulation of anatomical structure morphogenesis,BP
GO:0009628,8.364691997305716e-11,1,105,1225,response to abiotic stimulus,BP
GO:0005524,8.833201190596208e-11,1,121,1460,ATP binding,MF
GO:0080134,9.702627509326416e-11,1,124,1569,regulation of response to stress,BP
GO:0022613,9.845201692371398e-11,1,53,467,ribonucleoprotein complex biogenesis,BP
GO:0031175,9.982634345356353e-11,1,90,972,neuron projection development,BP
GO:0019221,1.0999227305138408e-10,1,75,775,cytokine-mediated signaling pathway,BP
GO:0006986,1.2585874771605908e-10,0.9999999999782203,30,175,response to unfolded protein,BP
GO:0048699,1.2662439948810148e-10,1,124,1515,generation of neurons,BP
GO:0046983,1.322718178561427e-10,1,109,1316,protein dimerization activity,MF
GO:1901565,1.4502137837122035e-10,1,108,1290,organonitrogen compound catabolic process,BP
GO:0060627,1.5787423127328728e-10,1,58,529,regulation of vesicle-mediated transport,BP
GO:0006518,1.6671969975896278e-10,1,77,875,peptide metabolic process,BP
GO:0097435,1.6688600197955983e-10,1,68,664,supramolecular fiber organization,BP
GO:0007399,1.6697784877436138e-10,1,173,2360,nervous system development,BP
GO:0072594,1.6986228417532729e-10,1,58,544,establishment of protein localization to organelle,BP
GO:0007267,1.7098023505414727e-10,1,131,1643,cell-cell signaling,BP
GO:0030182,1.778307065664623e-10,1,114,1356,neuron differentiation,BP
GO:0044430,1.883249238364252e-10,1,126,1584,cytoskeletal part,CC
GO:0042981,1.9410620683158063e-10,1,123,1566,regulation of apoptotic process,BP
GO:0006351,2.1736510586182695e-10,1,240,3615,"transcription, DNA-templated",BP
GO:0001816,2.1868334473648197e-10,1,74,778,cytokine production,BP
GO:0022402,2.616412939398111e-10,1,111,1384,cell cycle process,BP
GO:0098588,2.7248232449301613e-10,1,152,2051,bounding membrane of organelle,CC
GO:0097659,2.80815174994719e-10,1,242,3663,nucleic acid-templated transcription,BP
GO:0048468,2.8225177410006997e-10,1,160,2163,cell development,BP
GO:0042592,3.449381866648682e-10,1,142,1901,homeostatic process,BP
GO:0030554,4.1123738331499003e-10,1,123,1529,adenyl nucleotide binding,MF
GO:0045934,4.1969563101745064e-10,1,118,1466,negative regulation of nucleobase-containing compound metabolic process,BP
GO:0032774,4.2397172308580663e-10,1,242,3680,RNA biosynthetic process,BP
GO:0005694,4.4878230973141335e-10,1,91,1055,chromosome,CC
GO:0043604,4.6425535072416377e-10,1,75,858,amide biosynthetic process,BP
GO:0031327,5.023682754973757e-10,1,123,1610,negative regulation of cellular biosynthetic process,BP
GO:0032559,5.140859931372269e-10,1,122,1518,adenyl ribonucleotide binding,MF
GO:0044456,5.690766726903001e-10,1,86,936,synapse part,CC
GO:0072657,5.941497175662472e-10,1,62,618,protein localization to membrane,BP
GO:0006413,6.049083973292158e-10,0.9999999998695157,30,193,translational initiation,BP
GO:0006974,6.080767381887944e-10,1,78,848,cellular response to DNA damage stimulus,BP
GO:2000113,6.325179047437847e-10,1,114,1455,negative regulation of cellular macromolecule biosynthetic process,BP
GO:0009890,6.38297095029176e-10,1,124,1634,negative regulation of biosynthetic process,BP
GO:0031329,6.398628568858514e-10,1,79,867,regulation of cellular catabolic process,BP
GO:0043085,6.409343952467839e-10,1,114,1421,positive regulation of catalytic activity,BP
GO:0035966,6.641471623346428e-10,0.9999999998523258,31,198,response to topologically incorrect protein,BP
GO:0015031,6.789141006161033e-10,1,144,1983,protein transport,BP
GO:0051336,7.048227523795061e-10,1,105,1290,regulation of hydrolase activity,BP
GO:0032270,7.192384425450352e-10,1,124,1599,positive regulation of cellular protein metabolic process,BP
GO:0071705,7.350461831526988e-10,1,165,2357,nitrogen compound transport,BP
GO:0048666,7.537079187124396e-10,1,96,1104,neuron development,BP
GO:0097190,8.737213099398696e-10,1,61,598,apoptotic signaling pathway,BP
GO:0048585,8.936269408695753e-10,1,126,1668,negative regulation of response to stimulus,BP
GO:0002682,1.058386956579709e-9,1,118,1519,regulation of immune system process,BP
GO:0042886,1.0605111153289348e-9,1,147,2050,amide transport,BP
GO:0051253,1.087805899920619e-9,1,109,1336,negative regulation of RNA metabolic process,BP
GO:0002252,1.1291272410851312e-9,1,96,1150,immune effector process,BP
GO:0022626,1.1458618458964903e-9,0.9999999998227234,21,109,cytosolic ribosome,CC
GO:0010558,1.2032205419552414e-9,1,118,1543,negative regulation of macromolecule biosynthetic process,BP
GO:0015833,1.210794361447003e-9,1,145,2019,peptide transport,BP
GO:0006508,1.474240062609928e-9,1,133,1799,proteolysis,BP
GO:0030054,1.4947096202044466e-9,1,107,1297,cell junction,CC
GO:0001817,1.5373649187235624e-9,1,67,707,regulation of cytokine production,BP
GO:0051726,1.539844528184383e-9,1,98,1205,regulation of cell cycle,BP
GO:0023057,1.609459079360629e-9,1,110,1401,negative regulation of signaling,BP
GO:0060548,1.8481307134164157e-9,1,86,1005,negative regulation of cell death,BP
GO:0009968,1.8517859808582429e-9,1,103,1292,negative regulation of signal transduction,BP
GO:0008284,1.9157864399117708e-9,1,82,936,positive regulation of cell proliferation,BP
GO:0071495,1.921848928852667e-9,1,110,1383,cellular response to endogenous stimulus,BP
GO:0033365,2.0135761597148157e-9,1,80,916,protein localization to organelle,BP
GO:1903506,2.032707220105959e-9,1,230,3514,regulation of nucleic acid-templated transcription,BP
GO:0009615,2.0651663802617975e-9,1,41,326,response to virus,BP
GO:0006887,2.0944934096023527e-9,1,80,899,exocytosis,BP
GO:0120036,2.1102091542357326e-9,1,117,1488,plasma membrane bounded cell projection organization,BP
GO:0051247,2.120872627061486e-9,1,128,1701,positive regulation of protein metabolic process,BP
GO:0030030,2.340840693676075e-9,1,119,1525,cell projection organization,BP
GO:0009725,2.4079295300934414e-9,1,85,979,response to hormone,BP
GO:2001141,2.516208552339158e-9,1,230,3523,regulation of RNA biosynthetic process,BP
GO:0051092,2.5574299287418672e-9,0.9999999994848053,26,149,positive regulation of NF-kappaB transcription factor activity,BP
GO:0042493,2.6730325606083968e-9,1,87,1011,response to drug,BP
GO:0010648,2.6927151308491218e-9,1,109,1397,negative regulation of cell communication,BP
GO:0045597,2.8811457697211273e-9,1,85,982,positive regulation of cell differentiation,BP
GO:0006355,2.9894365774087236e-9,1,226,3454,"regulation of transcription, DNA-templated",BP
GO:0010243,3.121841801652951e-9,1,85,991,response to organonitrogen compound,BP
GO:0005525,3.1947870874565288e-9,1,44,369,GTP binding,MF
GO:1903508,3.4054717673491405e-09,1,123,1591,positive regulation of nucleic acid-templated transcription,BP
GO:0030163,3.4725175516111137e-9,1,81,926,protein catabolic process,BP
GO:1902680,3.5097197678825394e-9,1,123,1592,positive regulation of RNA biosynthetic process,BP
GO:1901701,3.6767444590497948e-9,1,93,1129,cellular response to oxygen-containing compound,BP
GO:0097458,3.696224765240189e-9,1,131,1721,neuron part,CC
GO:1901566,3.9458287998070405e-9,1,136,1932,organonitrogen compound biosynthetic process,BP
GO:0048471,4.016787271880081e-9,1,67,708,perinuclear region of cytoplasm,CC
GO:0002520,4.108315325064092e-9,1,84,974,immune system development,BP
GO:0032550,4.270409833300497e-9,1,44,373,purine ribonucleoside binding,MF
GO:0032940,4.290648631145401e-9,1,116,1514,secretion by cell,BP
GO:0042176,4.361449087779116e-9,1,44,378,regulation of protein catabolic process,BP
GO:0044427,5.09521589519858e-9,1,80,931,chromosomal part,CC
GO:0001883,5.446632137019513e-9,1,44,376,purine nucleoside binding,MF
GO:0031344,5.4730303943201025e-9,1,65,679,regulation of cell projection organization,BP
GO:0045664,5.782876131040873e-9,1,64,652,regulation of neuron differentiation,BP
GO:0043069,5.839497631073163e-9,1,79,916,negative regulation of programmed cell death,BP
GO:0032989,5.912616808416233e-9,1,95,1136,cellular component morphogenesis,BP
GO:0032549,5.916333433597681e-9,1,44,377,ribonucleoside binding,MF
GO:0000278,6.137544660562506e-9,1,84,1009,mitotic cell cycle,BP
GO:0098657,6.6592933741047415e-9,1,75,840,import into cell,BP
GO:0045893,6.953553710858634e-9,1,117,1506,"positive regulation of transcription, DNA-templated",BP
GO:0046903,7.188212803615013e-9,1,123,1649,secretion,BP
GO:0120035,7.50932289424589e-9,1,64,669,regulation of plasma membrane bounded cell projection organization,BP
GO:0040007,7.838376341927178e-9,1,83,972,growth,BP
GO:0000902,8.577449775078801e-9,1,88,1030,cell morphogenesis,BP
GO:0005794,9.137468425828476e-9,1,117,1536,Golgi apparatus,CC
GO:0006259,9.194696622181061e-9,1,84,1004,DNA metabolic process,BP
GO:1901698,9.322447702207276e-9,1,89,1080,response to nitrogen compound,BP
GO:0009967,9.652629416414688e-9,1,124,1677,positive regulation of signal transduction,BP
GO:0042127,9.726942146824795e-9,1,121,1663,regulation of cell proliferation,BP
GO:0060341,9.83311715495763e-9,1,78,899,regulation of cellular localization,BP
GO:0035239,9.974116561955758e-9,1,76,901,tube morphogenesis,BP
GO:0034620,1.0128242389474066e-8,0.9999999979129252,24,140,cellular response to unfolded protein,BP
GO:0001882,1.0318079741432179e-8,1,44,384,nucleoside binding,MF
GO:0031984,1.0661094261863293e-8,1,125,1685,organelle subcompartment,CC
GO:0030029,1.0685953991451384e-8,1,69,752,actin filament-based process,BP
GO:0035295,1.3938451969660427e-8,1,87,1087,tube development,BP
GO:0099080,1.3999426212267411e-8,1,77,865,supramolecular complex,CC
GO:0006928,1.4230123401302914e-8,1,147,2124,movement of cell or subcellular component,BP
GO:0010975,1.4287985437364291e-08,1,52,497,regulation of neuron projection development,BP
GO:0019001,1.4985647226449437e-8,1,44,389,guanyl nucleotide binding,MF
GO:0032561,1.4985647226449437e-8,1,44,389,guanyl ribonucleotide binding,MF
GO:0002253,1.5018190431709258e-8,1,58,601,activation of immune response,BP
GO:0001959,1.6041708869400214e-8,0.9999999961876362,27,175,regulation of cytokine-mediated signaling pathway,BP
GO:0007409,1.9682658660777763e-8,1,50,465,axonogenesis,BP
GO:0061564,1.98669404249949e-8,1,53,510,axon development,BP
GO:0006954,2.1487429413598985e-8,1,68,778,inflammatory response,BP
GO:0098794,2.1647564091011963e-8,1,60,612,postsynapse,CC
GO:0090150,2.1863395587893496e-8,0.9999999946615095,38,329,establishment of protein localization to membrane,BP
GO:0002684,2.2497666398210527e-8,1,86,1052,positive regulation of immune system process,BP
GO:0006897,2.312215460099184e-8,1,65,715,endocytosis,BP
GO:0051091,2.458557746310295e-8,0.9999999931823541,34,258,positive regulation of DNA-binding transcription factor activity,BP
GO:0000228,2.4672848833112437e-8,1,57,592,nuclear chromosome,CC
GO:0051050,2.719982462078223e-8,1,81,971,positive regulation of transport,BP
GO:0001775,2.801784985532376e-8,1,104,1359,cell activation,BP
GO:0099081,2.8134161540363832e-8,1,76,864,supramolecular polymer,CC
GO:0048534,2.8273675143534783e-8,1,78,921,hematopoietic or lymphoid organ development,BP
GO:0031347,2.9767477020132905e-8,1,71,828,regulation of defense response,BP
GO:0006886,3.2179246113709295e-8,1,88,1112,intracellular protein transport,BP
GO:0000904,3.262023712497205e-8,1,68,740,cell morphogenesis involved in differentiation,BP
GO:0043043,3.263899112230055e-8,1,61,721,peptide biosynthetic process,BP
GO:0010035,3.6044502023825485e-8,1,54,556,response to inorganic substance,BP
GO:0050778,3.6114507334174967e-8,1,68,771,positive regulation of immune response,BP
GO:0045892,3.728395427502746e-8,1,95,1194,"negative regulation of transcription, DNA-templated",BP
GO:0010952,3.956220046617863e-8,0.9999999897959357,28,196,positive regulation of peptidase activity,BP
GO:0044454,4.1841581999032454e-8,1,54,557,nuclear chromosome part,CC
GO:1903507,4.2197533674462384e-8,1,98,1247,negative regulation of nucleic acid-templated transcription,BP
GO:0016567,4.335320923802211e-8,1,71,816,protein ubiquitination,BP
GO:1902679,4.554850270975818e-8,1,98,1249,negative regulation of RNA biosynthetic process,BP
GO:0050767,4.6748595105997694e-8,1,72,817,regulation of neurogenesis,BP
GO:0030036,4.6956835136648204e-8,1,61,659,actin cytoskeleton organization,BP
GO:0050804,4.810978511843696e-8,1,47,435,modulation of chemical synaptic transmission,BP
GO:0051345,4.8530646382720706e-8,1,68,769,positive regulation of hydrolase activity,BP
GO:0098984,4.957776854913529e-8,0.9999999871414266,41,349,neuron to neuron synapse,CC
GO:0099177,5.0912474043120315e-8,1,47,436,regulation of trans-synaptic signaling,BP
GO:0001961,5.466492467745458e-8,0.9999999935765674,14,50,positive regulation of cytokine-mediated signaling pathway,BP
GO:0016072,5.649697824277994e-8,0.9999999843864052,32,252,rRNA metabolic process,BP
GO:0048646,5.682077786134913e-8,1,89,1153,anatomical structure formation involved in morphogenesis,BP
GO:0040011,5.774152168216583e-8,1,131,1890,locomotion,BP
GO:0060759,6.300359206303196e-8,0.9999999838578543,27,186,regulation of response to cytokine stimulus,BP
GO:0010950,6.955654201342101e-8,0.9999999826418096,26,177,positive regulation of endopeptidase activity,BP
GO:0099003,7.550988164353912e-8,0.9999999795536796,29,205,vesicle-mediated transport in synapse,BP
GO:0050776,7.597659634528721e-8,1,80,984,regulation of immune response,BP
GO:0043122,7.62291817499246e-8,0.9999999782560852,31,235,regulation of I-kappaB kinase/NF-kappaB signaling,BP
GO:0032990,7.687576203402301e-8,1,63,681,cell part morphogenesis,BP
GO:0030097,7.842324670799144e-8,1,74,880,hemopoiesis,BP
GO:0032606,8.341491062899613e-8,0.9999999820461835,22,128,type I interferon production,BP
GO:0006412,9.798050432089839e-8,1,58,696,translation,BP
GO:0016049,1.0261527230740376e-7,1,48,476,cell growth,BP
GO:1903047,1.0609354495458879e-7,1,71,866,mitotic cell cycle process,BP
GO:0043066,1.0639310023279076e-7,1,74,897,negative regulation of apoptotic process,BP
GO:0000785,1.0765500466259446e-7,1,52,546,chromatin,CC
GO:0046677,1.2183009055511324e-7,0.9999999620260804,37,323,response to antibiotic,BP
GO:0048812,1.2714423942688172e-7,1,60,644,neuron projection morphogenesis,BP
GO:0015630,1.3108407632859452e-7,1,92,1189,microtubule cytoskeleton,CC
GO:0005783,1.417416728785258e-7,1,131,1884,endoplasmic reticulum,CC
GO:0035967,1.579344696606635e-7,0.9999999614661742,24,161,cellular response to topologically incorrect protein,BP
GO:0043903,1.663497639009669e-7,0.9999999530003516,29,222,"regulation of symbiosis, encompassing mutualism through parasitism",BP
GO:0048608,1.701435237257157e-7,0.9999999523094911,45,425,reproductive structure development,BP
GO:0099512,1.7265141209235488e-7,1,73,857,supramolecular fiber,CC
GO:0005198,1.8251849639929117e-7,1,64,748,structural molecule activity,MF
GO:0003677,1.8579259974357108e-7,1,164,2464,DNA binding,MF
GO:0051090,1.8923950750197619e-7,0.9999999472412305,44,422,regulation of DNA-binding transcription factor activity,BP
GO:0007417,1.8931503718590256e-7,1,81,992,central nervous system development,BP
GO:0005768,1.8947918540195616e-7,1,73,881,endosome,CC
GO:0061458,2.0083620450730943e-7,0.9999999434336366,45,428,reproductive system development,BP
GO:0045055,2.0226867171786245e-7,1,67,790,regulated exocytosis,BP
GO:0022618,2.0959502109434583e-7,0.9999999378470382,30,243,ribonucleoprotein complex assembly,BP
GO:0046982,2.272088609958355e-7,0.9999999340833511,48,497,protein heterodimerization activity,MF
GO:0048667,2.331395422210902e-7,1,55,579,cell morphogenesis involved in neuron differentiation,BP
GO:0048545,2.4787140644075415e-7,0.9999999162919668,41,382,response to steroid hormone,BP
GO:0016772,2.518454438136666e-7,1,75,909,"transferase activity, transferring phosphorus-containing groups",MF
GO:0120039,2.601792085453827e-7,1,60,658,plasma membrane bounded cell projection morphogenesis,BP
GO:0016740,2.6694823400187935e-7,1,151,2259,transferase activity,MF
GO:0012506,2.7522605912631967e-7,1,66,772,vesicle membrane,CC
GO:0048870,2.8488688703802653e-7,1,115,1664,cell motility,BP
GO:0051674,2.8488688703802653e-7,1,115,1664,localization of cell,BP
GO:0140096,2.874766220538871e-7,1,145,2156,"catalytic activity, acting on a protein",MF
GO:0032479,2.8757081382826615e-7,0.9999999358101582,21,126,regulation of type I interferon production,BP
GO:0016477,2.9863736556292026e-7,1,106,1505,cell migration,BP
GO:0030968,3.215014030994869e-7,0.9999999308256375,20,121,endoplasmic reticulum unfolded protein response,BP
GO:0051960,3.2211919893555173e-7,1,76,922,regulation of nervous system development,BP
GO:0060760,3.2333090275468234e-7,0.9999999547165827,14,57,positive regulation of response to cytokine stimulus,BP
GO:0032446,3.304332330794967e-7,1,73,900,protein modification by small protein conjugation,BP
GO:0017111,3.596365223999743e-7,1,71,854,nucleoside-triphosphatase activity,MF
GO:0016462,3.6128034151800997e-7,1,74,903,pyrophosphatase activity,MF
GO:0050769,3.6822562138685885e-7,0.99999989268038,47,469,positive regulation of neurogenesis,BP
GO:0072359,3.721482691075823e-7,1,85,1147,circulatory system development,BP
GO:0006396,3.755432426578412e-7,1,84,1297,RNA processing,BP
GO:0016310,3.8165091866260606e-7,1,155,2385,phosphorylation,BP
GO:0000956,3.825695459868207e-7,0.999999894577555,26,207,nuclear-transcribed mRNA catabolic process,BP
GO:0022625,3.924231390172427e-7,0.9999999479813363,13,61,cytosolic large ribosomal subunit,CC
GO:0070997,4.0169210253859627e-7,0.9999998595032896,38,345,neuron death,BP
GO:0007249,4.0734618130476713e-7,0.9999998696589075,32,267,I-kappaB kinase/NF-kappaB signaling,BP
GO:0042803,4.1919986568236676e-7,1,70,853,protein homodimerization activity,MF
GO:0034248,4.2554179686705113e-7,0.9999998496719128,43,469,regulation of cellular amide metabolic process,BP
GO:0005102,4.521001071458259e-7,1,109,1534,signaling receptor binding,MF
GO:0014069,4.649291796981899e-7,0.9999998390267826,37,323,postsynaptic density,CC
GO:0048858,4.6959083219105645e-7,0.9999998506880751,60,662,cell projection morphogenesis,BP
GO:0003779,4.801677865526455e-7,0.9999998284969928,44,430,actin binding,MF
GO:0002757,4.981658559270571e-7,0.9999998512749457,49,518,immune response-activating signal transduction,BP
GO:0044432,5.059986627832295e-7,1,98,1336,endoplasmic reticulum part,CC
GO:0071407,5.191887067942996e-7,0.9999998427423968,51,539,cellular response to organic cyclic compound,BP
GO:0050792,5.289050902334397e-7,0.9999998478222171,27,208,regulation of viral process,BP
GO:0060249,5.290026228446925e-7,0.9999998121960214,43,431,anatomical structure homeostasis,BP
GO:0044440,5.771680005505594e-7,0.9999998282525564,48,503,endosomal part,CC
GO:0035690,5.803895659417074e-7,0.9999997908797366,39,368,cellular response to drug,BP
GO:0006364,5.955123114544149e-7,0.9999998269051306,27,213,rRNA processing,BP
GO:0016050,5.97450642027492e-7,0.9999997904158854,36,324,vesicle organization,BP
GO:0016817,6.12807705059345e-7,0.9999997925033969,74,906,"hydrolase activity, acting on acid anhydrides",MF
GO:0016818,6.12807705059345e-7,0.9999997925033969,74,906,"hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides",MF
GO:1901214,6.228104432606694e-7,0.9999997847764196,35,311,regulation of neuron death,BP
GO:1903900,6.368468918846205e-7,0.9999998429095871,22,149,regulation of viral life cycle,BP
GO:0032279,6.529818323009668e-7,0.9999997666404681,37,327,asymmetric synapse,CC
GO:0009888,6.54108532813916e-7,0.9999997509179743,134,1962,tissue development,BP
GO:0060322,6.593523695860592e-7,0.9999997829259304,66,768,head development,BP
GO:0051701,7.018678422105452e-7,0.9999997943994761,27,209,interaction with host,BP
GO:0002237,7.194033780545444e-7,0.9999997413713707,37,342,response to molecule of bacterial origin,BP
GO:0032355,7.281405333146427e-7,0.999999826631437,21,134,response to estradiol,BP
GO:0140097,7.437600759837664e-7,0.9999997815649871,27,207,"catalytic activity, acting on DNA",MF
GO:0008134,7.544349108743174e-7,0.9999997597064214,58,656,transcription factor binding,MF
GO:0071826,7.595749206994074e-7,0.9999997586005301,30,257,ribonucleoprotein complex subunit organization,BP
GO:0010638,7.615351324560186e-7,0.9999997611885003,55,619,positive regulation of organelle organization,BP
GO:0032496,7.680978166187504e-7,0.9999997274286556,36,329,response to lipopolysaccharide,BP
GO:0001944,8.102935776156925e-7,0.9999997361589814,62,775,vasculature development,BP
GO:0045069,8.71241815870099e-7,0.9999998292837995,17,95,regulation of viral genome replication,BP
GO:0040008,8.868166665485312e-7,0.9999997163689431,58,667,regulation of growth,BP
GO:0000122,9.116896042583377e-7,0.9999996941651841,69,827,negative regulation of transcription by RNA polymerase II,BP
GO:0070647,9.125311458592863e-7,0.9999996792792407,84,1100,protein modification by small protein conjugation or removal,BP
GO:0072599,9.45135448563794e-7,0.9999998001192765,18,119,establishment of protein localization to endoplasmic reticulum,BP
GO:0050673,9.53664237249497e-7,0.9999996398430201,41,421,epithelial cell proliferation,BP
GO:0044257,9.670259593078787e-7,0.999999681378605,64,768,cellular protein catabolic process,BP
GO:0009790,9.794538975918472e-7,0.999999659089619,80,1010,embryo development,BP
GO:0045666,9.845597751911594e-7,0.9999996307554759,39,367,positive regulation of neuron differentiation,BP
GO:2000116,1.0190333222240325e-6,0.9999996792211528,29,238,regulation of cysteine-type endopeptidase activity,BP
GO:0003725,1.0245842116770069e-6,0.9999998236634352,15,75,double-stranded RNA binding,MF
GO:0022414,1.0276383205707422e-6,0.9999996230698509,103,1417,reproductive process,BP
GO:0099572,1.0341667434526145e-6,0.9999996171033534,38,347,postsynaptic specialization,CC
GO:0003924,1.1137647719339299e-6,0.9999996045731605,35,320,GTPase activity,MF
GO:0000003,1.1198365475445697e-6,0.9999995886703663,103,1420,reproduction,BP
GO:0019080,1.1688993509289583e-6,0.9999996760947087,24,191,viral gene expression,BP
GO:0009617,1.1977646248304256e-6,0.9999996219881344,54,627,response to bacterium,BP
GO:0000723,1.1985130581475696e-6,0.9999996909311362,22,160,telomere maintenance,BP
GO:0043281,1.2122855856662206e-6,0.9999996337388676,27,214,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP
GO:0052548,1.2400958893111832e-6,0.9999995169073201,41,421,regulation of endopeptidase activity,BP
GO:0048525,1.2705739986443804e-6,0.9999997428196409,17,99,negative regulation of viral process,BP
GO:0070972,1.3125432437503636e-6,0.999999685862444,20,143,protein localization to endoplasmic reticulum,BP
GO:0005844,1.3181096137010256e-6,0.999999784603862,14,72,polysome,CC
GO:0051607,1.3216215530376783e-6,0.9999995783293587,29,238,defense response to virus,BP
GO:1902533,1.3485472740707078e-6,0.9999995249996657,82,1075,positive regulation of intracellular signal transduction,BP
GO:0060284,1.4310649521145105e-6,0.9999995053931413,75,945,regulation of cell development,BP
GO:1902494,1.4341285795555117e-6,0.9999994767583938,97,1355,catalytic complex,CC
GO:0072358,1.4841389562136325e-6,0.9999993753489439,62,784,cardiovascular system development,BP
GO:0032880,1.5053048686763894e-6,0.9999994759040953,77,1002,regulation of protein localization,BP
GO:0010008,1.5199801986913993e-6,0.9999993963556314,44,456,endosome membrane,CC
GO:0030659,1.5999629420032234e-6,0.9999993227419104,63,751,cytoplasmic vesicle membrane,CC
GO:0042254,1.6121695411901461e-6,0.9999994444611787,32,294,ribosome biogenesis,BP
GO:0001558,1.6202650938465504e-6,0.9999993625500966,41,410,regulation of cell growth,BP
GO:0017157,1.6253310205146786e-6,0.9999995008900721,27,215,regulation of exocytosis,BP
GO:0006614,1.696583537224589e-6,0.999999666574479,16,102,SRP-dependent cotranslational protein targeting to membrane,BP
GO:0097153,1.7071874794358922e-6,0.9999999209388946,7,15,cysteine-type endopeptidase activity involved in apoptotic process,MF
GO:0010976,1.7141811831526951e-6,0.999999408784929,32,280,positive regulation of neuron projection development,BP
GO:0048146,1.7374957641295848e-6,0.9999997638058524,12,51,positive regulation of fibroblast proliferation,BP
GO:0051962,1.7506591445561354e-6,0.9999993129270549,50,536,positive regulation of nervous system development,BP
GO:0044459,1.817993947918605e-6,0.9999990441701943,180,2784,plasma membrane part,CC
GO:0019079,1.9508238601722414e-6,0.9999995446133337,19,122,viral genome replication,BP
GO:0044431,2.022820999677652e-6,0.9999990953185123,75,952,Golgi apparatus part,CC
GO:0022604,2.070031305090614e-6,0.999999152354354,46,482,regulation of cell morphogenesis,BP
GO:0022610,2.1002792875497176e-6,0.999998989133398,103,1415,biological adhesion,BP
GO:1901652,2.3095754463777097e-6,0.9999990408088756,47,518,response to peptide,BP
GO:0036293,2.3239317097342306e-6,0.9999991132537519,37,365,response to decreased oxygen levels,BP
GO:0044283,2.346176253317499e-6,0.9999989872654274,65,804,small molecule biosynthetic process,BP
GO:0045047,2.3592093415577035e-6,0.9999994930618975,17,115,protein targeting to ER,BP
GO:0099513,2.4807055501737763e-6,0.9999989763990306,56,637,polymeric cytoskeletal fiber,CC
GO:0052547,2.482013355942912e-6,0.9999989930570692,42,448,regulation of peptidase activity,BP
GO:0071396,2.5105353166937104e-6,0.9999989821123116,53,607,cellular response to lipid,BP
GO:0006979,2.539737296008131e-6,0.9999989689711121,42,444,response to oxidative stress,BP
GO:0034470,2.552493811924673e-6,0.9999990074705584,38,383,ncRNA processing,BP
GO:0051384,2.663836809064979e-6,0.9999993056109131,21,145,response to glucocorticoid,BP
GO:0042995,2.741668530160269e-6,0.9999984479313816,144,2167,cell projection,CC
GO:0043123,2.8348253839435805e-6,0.9999991737138394,24,183,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP
GO:0007155,2.867379669637951e-6,0.9999986145366603,102,1408,cell adhesion,BP
GO:0019900,2.9037975340849153e-6,0.9999986610085487,61,727,kinase binding,MF
GO:0042788,2.913289354614153e-6,0.9999997285255469,9,32,polysomal ribosome,CC
GO:0009611,2.9790335802886265e-6,0.9999987564970492,57,675,response to wounding,BP
GO:0006613,2.988726667627804e-6,0.9999993834763997,16,106,cotranslational protein targeting to membrane,BP
GO:0051656,3.002507975721879e-6,0.9999987528538863,46,500,establishment of organelle localization,BP
GO:0032200,3.086821993637707e-6,0.9999991511476098,22,171,telomere organization,BP
GO:0051248,3.1010079999044926e-6,0.9999985631053883,83,1168,negative regulation of protein metabolic process,BP
GO:2001056,3.183853401042452e-6,0.9999991590039691,21,148,positive regulation of cysteine-type endopeptidase activity,BP
GO:0044281,3.29955824147282e-6,0.9999981438424441,136,2089,small molecule metabolic process,BP
GO:1903901,3.3319667601149358e-6,0.9999993583091958,15,85,negative regulation of viral life cycle,BP
GO:0050770,3.379405642980223e-6,0.9999990047439711,24,182,regulation of axonogenesis,BP
GO:0051338,3.414333739909794e-6,0.9999983153218795,75,966,regulation of transferase activity,BP
GO:0002764,3.464563304260397e-6,0.9999985156773573,49,551,immune response-regulating signaling pathway,BP
GO:0044087,3.4679712288421904e-6,0.9999983008497353,73,943,regulation of cellular component biogenesis,BP
GO:0006325,3.5085416735572505e-6,0.9999984831565124,63,783,chromatin organization,BP
GO:0032101,3.5141061738013124e-6,0.9999984601705942,66,843,regulation of response to external stimulus,BP
GO:0016773,3.5737397135698784e-6,0.9999983605303813,59,693,"phosphotransferase activity, alcohol group as acceptor",MF
GO:0045321,3.5904175763787544e-6,0.9999981504176605,88,1203,leukocyte activation,BP
GO:0060429,3.6588101830254265e-6,0.9999981097601363,89,1195,epithelium development,BP
GO:0071887,3.6644998884006354e-6,0.9999991919246991,17,104,leukocyte apoptotic process,BP
GO:0070482,3.7049985897587018e-6,0.9999985348463143,38,388,response to oxygen levels,BP
GO:0071897,3.827094092755259e-6,0.9999988612357914,24,191,DNA biosynthetic process,BP
GO:0045944,3.859516143352528e-6,0.999998003892529,89,1186,positive regulation of transcription by RNA polymerase II,BP
GO:0034976,3.871181510286414e-6,0.999998630701384,31,284,response to endoplasmic reticulum stress,BP
GO:0005840,3.914611254778095e-6,0.9999986969103354,28,262,ribosome,CC
GO:0016055,3.976955078247934e-6,0.999998316544087,47,516,Wnt signaling pathway,BP
GO:0019058,4.062071788206054e-6,0.9999984786533309,34,328,viral life cycle,BP
GO:0070201,4.2125869956250515e-6,0.9999980454958527,60,737,regulation of establishment of protein localization,BP
GO:0198738,4.404946316906869e-6,0.9999981284121674,47,518,cell-cell signaling by wnt,BP
GO:0071417,4.420953495642341e-6,0.9999980605213175,51,583,cellular response to organonitrogen compound,BP
GO:0097193,4.460415973592317e-6,0.9999984103072196,31,286,intrinsic apoptotic signaling pathway,BP
GO:0007420,4.461824383500133e-6,0.9999979166721016,61,725,brain development,BP
GO:1901699,4.534807166329153e-6,0.9999979534660974,55,646,cellular response to nitrogen compound,BP
GO:0000184,4.571121917385833e-6,0.9999989630719793,17,120,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",BP
GO:0031346,4.589875161724406e-6,0.9999981685537154,38,382,positive regulation of cell projection organization,BP
GO:1903362,4.859260968128272e-6,0.9999983682743534,28,244,regulation of cellular protein catabolic process,BP
GO:0006468,4.897858653722286e-6,0.9999972476235625,130,1970,protein phosphorylation,BP
GO:0080135,4.952409954107171e-6,0.9999976909799402,60,740,regulation of cellular response to stress,BP
GO:0098791,5.026441577509729e-6,0.9999975744057047,67,838,Golgi subcompartment,CC
GO:0006919,5.147349450845728e-6,0.9999989712570325,15,85,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP
GO:0009636,5.2542216506193175e-6,0.9999977114288545,46,517,response to toxic substance,BP
GO:0005773,5.363048020864651e-6,0.9999974802320223,61,756,vacuole,CC
GO:0097440,5.421865477088802e-6,0.9999996801457558,7,17,apical dendrite,CC
GO:1901654,5.498680309115586e-6,0.9999983271451589,24,191,response to ketone,BP
GO:0070306,5.937924006601104e-6,0.9999993986502801,9,31,lens fiber cell differentiation,BP
GO:0042060,6.0945694329251354e-06,0.9999973362963875,49,562,wound healing,BP
GO:0000790,6.127313650618556e-6,0.9999975836527887,36,362,nuclear chromatin,CC
GO:0044391,6.27434275131058e-6,0.9999981845541408,22,187,ribosomal subunit,CC
GO:0006629,6.498472676894203e-6,0.9999963712768271,98,1399,lipid metabolic process,BP
GO:0016301,6.534570279089199e-6,0.9999968971241535,62,758,kinase activity,MF
GO:0031399,6.5459644646190705e-6,0.9999960695101231,123,1851,regulation of protein modification process,BP
GO:0043280,6.5893366735763705e-6,0.9999983128625958,19,131,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP
GO:0043487,6.708976535612121e-6,0.9999979941273193,23,183,regulation of RNA stability,BP
GO:0001666,7.175628780256071e-6,0.9999971898079518,35,354,response to hypoxia,BP
GO:0051603,7.191611389936823e-6,0.9999965349098409,58,711,proteolysis involved in cellular protein catabolic process,BP
GO:0120025,7.1918625296058476e-6,0.9999955764491775,138,2092,plasma membrane bounded cell projection,CC
GO:0002429,7.559561467955643e-6,0.9999970332036547,35,350,immune response-activating cell surface receptor signaling pathway,BP
GO:0009895,7.675704285453802e-6,0.9999971317966615,32,306,negative regulation of catabolic process,BP
GO:0001819,8.214880848066434e-6,0.9999964660905714,42,457,positive regulation of cytokine production,BP
GO:0035770,8.232601951603036e-6,0.9999972835261458,26,222,ribonucleoprotein granule,CC
GO:1903050,8.326817574431161e-6,0.9999973211430316,25,211,regulation of proteolysis involved in cellular protein catabolic process,BP
GO:0061013,8.483983273572611e-6,0.9999973431520413,24,199,regulation of mRNA catabolic process,BP
GO:0045136,8.808747526278122e-6,0.9999997970161268,5,8,development of secondary sexual characteristics,BP
GO:1903530,9.125997611827153e-6,0.9999955170831236,60,745,regulation of secretion by cell,BP
GO:0030234,9.224775456168386e-6,0.9999951273019023,76,1028,enzyme regulator activity,MF
GO:0036464,9.639777148880348e-6,0.9999968711028994,25,211,cytoplasmic ribonucleoprotein granule,CC
GO:1901342,1.0004389489371136e-5,0.9999960008841906,35,407,regulation of vasculature development,BP
GO:0001568,1.0033527816715009e-5,0.999995135068815,57,744,blood vessel development,BP
GO:0097199,1.0348129444722783e-5,0.9999997532458446,5,8,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF
GO:0099504,1.0410600259375251e-5,0.9999967038380575,24,192,synaptic vesicle cycle,BP
GO:0048514,1.0645807440114912e-5,0.9999949932909329,52,665,blood vessel morphogenesis,BP
GO:0031349,1.0813209031315235e-5,0.9999951456489956,45,514,positive regulation of defense response,BP
GO:0051098,1.1006801923041256e-5,0.9999955335960199,36,371,regulation of binding,BP
GO:0005938,1.1709078858639934e-5,0.9999955245469477,32,308,cell cortex,CC
GO:0019220,1.1710913620375119e-5,0.9999929289204391,119,1801,regulation of phosphate metabolic process,BP
GO:0006281,1.1868306233229905e-5,0.9999946158849408,47,547,DNA repair,BP
GO:0060560,1.2016477119283421e-5,0.9999958467215674,27,234,developmental growth involved in morphogenesis,BP
GO:0015629,1.2212219699297211e-5,0.999994492966092,45,505,actin cytoskeleton,CC
GO:0005764,1.2254469374364183e-5,0.9999941355225361,54,660,lysosome,CC
GO:0051174,1.2341063909544228e-5,0.9999925400210207,119,1803,regulation of phosphorus metabolic process,BP
GO:0000323,1.2668010975083179e-5,0.9999939304228675,54,661,lytic vacuole,CC
GO:1903706,1.309381404021717e-5,0.9999942273550756,42,470,regulation of hemopoiesis,BP
GO:0016311,1.32553121875517e-5,0.9999941187191078,43,475,dephosphorylation,BP
GO:0099537,1.33102678989884e-5,0.9999933214406906,59,709,trans-synaptic signaling,BP
GO:0002181,1.3322079385407533e-5,0.9999970704958673,15,99,cytoplasmic translation,BP
GO:0031960,1.3393600029870556e-5,0.9999960799076744,21,161,response to corticosteroid,BP
GO:0005200,1.3609423878815113e-5,0.9999968332592978,16,101,structural constituent of cytoskeleton,MF
GO:0072659,1.4362006332674974e-5,0.9999948592151895,28,260,protein localization to plasma membrane,BP
GO:0005769,1.5031536016036728e-5,0.9999939830216014,34,341,early endosome,CC
GO:0009314,1.514459061796096e-5,0.999993357062073,41,447,response to radiation,BP
GO:0009991,1.5430402306268434e-5,0.9999929070269276,46,530,response to extracellular stimulus,BP
GO:0051640,1.5833660009360366e-5,0.9999921438247933,56,695,organelle localization,BP
GO:0005739,1.6332273815000694e-5,0.9999903602012844,103,1548,mitochondrion,CC
GO:0099536,1.6877525174383603e-5,0.999991461021438,59,715,synaptic signaling,BP
GO:0046890,1.696992441766769e-5,0.9999945916659998,23,198,regulation of lipid biosynthetic process,BP
GO:0048144,1.7469397158148055e-5,0.9999963404307791,14,84,fibroblast proliferation,BP
GO:0048661,1.8162072033989752e-5,0.9999958898285202,15,101,positive regulation of smooth muscle cell proliferation,BP
GO:0007268,1.8264534842486675e-5,0.9999907874189298,58,701,chemical synaptic transmission,BP
GO:0098916,1.8264534842486675e-5,0.9999907874189298,58,701,anterograde trans-synaptic signaling,BP
GO:0032608,1.8515440071597074e-5,0.9999970658861197,11,50,interferon-beta production,BP
GO:0048732,1.8548811587114834e-5,0.9999918848558642,40,427,gland development,BP
GO:0061180,1.8952065808171257e-5,0.999996308267595,13,72,mammary gland epithelium development,BP
GO:0044425,1.907918660024271e-5,0.9999858857942497,367,6661,membrane part,CC
GO:0045786,1.9221396931303436e-5,0.9999907101171158,51,635,negative regulation of cell cycle,BP
GO:0006366,1.9438109895724217e-5,0.9999870114197765,173,2786,transcription by RNA polymerase II,BP
GO:0030863,1.967285432899369e-5,0.9999950023485813,17,116,cortical cytoskeleton,CC
GO:0030900,1.9915620917527472e-5,0.9999915668214218,37,379,forebrain development,BP
GO:0010720,2.0536412495544776e-5,0.999990366922831,47,546,positive regulation of cell development,BP
GO:0048489,2.058487085428235e-5,0.9999940106666341,20,151,synaptic vesicle transport,BP
GO:0097480,2.058487085428235e-5,0.9999940106666341,20,151,establishment of synaptic vesicle localization,BP
GO:0044389,2.1121967108282437e-5,0.9999918003304815,31,308,ubiquitin-like protein ligase binding,MF
GO:0090305,2.1271859580850916e-5,0.9999918869875767,30,295,nucleic acid phosphodiester bond hydrolysis,BP
GO:0010631,2.1382456580074522e-5,0.9999916646841807,31,341,epithelial cell migration,BP
GO:1903311,2.1679324185460124e-5,0.9999914240340836,32,324,regulation of mRNA metabolic process,BP
GO:0007163,2.1731449533681762e-5,0.9999927594926232,24,210,establishment or maintenance of cell polarity,BP
GO:0007623,2.304055803520223e-5,0.9999922997252106,24,207,circadian rhythm,BP
GO:0046914,2.319308177368529e-5,0.9999869622580869,78,1068,transition metal ion binding,MF
GO:0048729,2.3947737778338178e-5,0.999987941094907,55,665,tissue morphogenesis,BP
GO:0051046,2.431969840454029e-5,0.9999872242575943,62,803,regulation of secretion,BP
GO:0030684,2.4586778816547357e-5,0.9999950604656445,13,76,preribosome,CC
GO:0098542,2.4725371962127892e-5,0.9999887753611342,42,496,defense response to other organism,BP
GO:0001525,2.4856188057865803e-5,0.9999883648851233,45,574,angiogenesis,BP
GO:0090132,2.554738834113431e-5,0.9999899420081091,31,344,epithelium migration,BP
GO:0044297,2.5838392122965492e-5,0.9999875994748374,48,560,cell body,CC
GO:0051259,2.584185371710278e-5,0.9999877565186641,47,563,protein complex oligomerization,BP
GO:0033002,2.585165516793931e-5,0.9999912508216541,24,233,muscle cell proliferation,BP
GO:0045088,2.600160597877568e-5,0.9999884146995603,40,447,regulation of innate immune response,BP
GO:0043900,2.6390358613936964e-5,0.999988648753146,37,405,regulation of multi-organism process,BP
GO:0001655,2.7332302169979914e-5,0.9999888870763973,33,329,urogenital system development,BP
GO:1905114,2.7767886754039237e-5,0.9999863975372365,51,619,cell surface receptor signaling pathway involved in cell-cell signaling,BP
GO:0007346,2.79440833261055e-5,0.9999862940261928,51,649,regulation of mitotic cell cycle,BP
GO:0030424,2.7952796866414284e-5,0.9999863109565473,51,604,axon,CC
GO:0019901,2.813447185883854e-5,0.999985929128465,53,648,protein kinase binding,MF
GO:0032386,2.8234587440344623e-5,0.9999876620204605,38,420,regulation of intracellular transport,BP
GO:0043542,2.82360423581415e-5,0.9999901149322221,25,263,endothelial cell migration,BP
GO:0050821,2.876624789806985e-5,0.9999910841494566,21,173,protein stabilization,BP
GO:0000186,3.007905572243892e-5,0.9999949283577947,11,53,activation of MAPKK activity,BP
GO:0036473,3.0472846143559518e-5,0.9999932192871662,14,93,cell death in response to oxidative stress,BP
GO:0050851,3.1002863269785435e-5,0.9999891382588723,25,231,antigen receptor-mediated signaling pathway,BP
GO:0001505,3.2314033119374704e-5,0.9999865318351794,34,352,regulation of neurotransmitter levels,BP
GO:0097278,3.257389075200521e-5,0.9999987838399006,5,10,complement-dependent cytotoxicity,BP
GO:0048511,3.260349075888152e-5,0.9999872681377172,30,294,rhythmic process,BP
GO:0071222,3.387208016802167e-5,0.9999886857021216,23,204,cellular response to lipopolysaccharide,BP
GO:0043005,3.533412701318896e-5,0.9999788880922001,92,1307,neuron projection,CC
GO:0010876,3.534589624915617e-5,0.9999847618452189,36,397,lipid localization,BP
GO:0003006,3.5422862446458665e-5,0.9999820050877701,54,668,developmental process involved in reproduction,BP
GO:1903827,3.558644577652034e-5,0.9999832665079698,44,520,regulation of cellular protein localization,BP
GO:0048660,3.574475259008386e-5,0.999989475017491,19,167,regulation of smooth muscle cell proliferation,BP
GO:0042325,3.5966814177883825e-5,0.9999777717953257,106,1602,regulation of phosphorylation,BP
GO:0051262,3.599543097505313e-5,0.999989024012887,20,169,protein tetramerization,BP
GO:0045071,3.647727977235586e-5,0.9999936341901009,11,59,negative regulation of viral genome replication,BP
GO:0090130,3.753389073944371e-5,0.9999849012446017,31,350,tissue migration,BP
GO:0071496,3.7810855480845226e-5,0.9999843456878958,33,339,cellular response to external stimulus,BP
GO:0048589,3.81435647855132e-5,0.9999806893976254,53,663,developmental growth,BP
GO:0048027,3.9103656668042894e-5,0.9999964387966934,7,25,mRNA 5'-UTR binding,MF
GO:0019083,4.017069849335538e-5,0.99998762336869,20,177,viral transcription,BP
GO:1904018,4.0419217660578736e-5,0.9999862780579879,23,226,positive regulation of vasculature development,BP
GO:0043632,4.0425084827323856e-5,0.9999797091878027,51,634,modification-dependent macromolecule catabolic process,BP
GO:0006511,4.052138749801913e-5,0.9999798648133399,50,617,ubiquitin-dependent protein catabolic process,BP
GO:0043488,4.054502524419335e-5,0.9999871087846879,21,177,regulation of mRNA stability,BP
GO:0030100,4.092708234499429e-5,0.9999843869613639,28,280,regulation of endocytosis,BP
GO:0072001,4.159235179778741e-5,0.9999835381663844,30,292,renal system development,BP
GO:0006949,4.189590124923798e-5,0.9999926330504829,11,55,syncytium formation,BP
GO:0034660,4.1946060160604317e-5,0.9999797718075802,46,561,ncRNA metabolic process,BP
GO:0033267,4.202126992318786e-5,0.9999817490357914,36,381,axon part,CC
GO:0043254,4.28605725629488e-5,0.9999804363078498,40,462,regulation of protein complex assembly,BP
GO:0043549,4.310715591294344e-5,0.9999765550060897,65,864,regulation of kinase activity,BP
GO:0007548,4.354128366482528e-5,0.9999833611192478,28,266,sex differentiation,BP
GO:0048659,4.3777231196163706e-5,0.9999869018674331,19,169,smooth muscle cell proliferation,BP
GO:0009612,4.378881004035131e-5,0.9999847342309766,24,210,response to mechanical stimulus,BP
GO:0051099,4.564685406973651e-5,0.999985359169675,21,178,positive regulation of binding,BP
GO:0042542,4.60554369394948e-5,0.9999867715840463,18,144,response to hydrogen peroxide,BP
GO:0001837,4.61105420672541e-5,0.9999867813411321,18,139,epithelial to mesenchymal transition,BP
GO:0051650,4.6574617921023396e-5,0.9999817633587432,29,287,establishment of vesicle localization,BP
GO:0006605,4.748100435065951e-5,0.9999789353854497,37,429,protein targeting,BP
GO:0071216,4.811509737816538e-5,0.9999826540858852,25,235,cellular response to biotic stimulus,BP
GO:2001233,4.864538419620944e-5,0.999978681277321,36,402,regulation of apoptotic signaling pathway,BP
GO:0010564,4.8802902768989966e-5,0.9999741629099359,58,782,regulation of cell cycle process,BP
GO:0016788,4.896877923741771e-5,0.9999742427613086,57,734,"hydrolase activity, acting on ester bonds",MF
GO:0002768,5.007279672193835e-5,0.999978320921661,35,382,immune response-regulating cell surface receptor signaling pathway,BP
GO:0098687,5.0143392284888666e-5,0.9999792071273652,32,345,chromosomal region,CC
GO:0019941,5.053485032054721e-5,0.9999746591178926,50,623,modification-dependent protein catabolic process,BP
GO:0006909,5.058225620176644e-5,0.9999808540164254,27,266,phagocytosis,BP
GO:0003727,5.096212452427318e-5,0.9999881056080366,14,92,single-stranded RNA binding,MF
GO:0003730,5.2187299204867066e-5,0.9999878025143185,14,91,mRNA 3'-UTR binding,MF
GO:0036477,5.2433082869637175e-5,0.9999713044741849,64,839,somatodendritic compartment,CC
GO:0007015,5.286996279968563e-5,0.9999767422122814,36,396,actin filament organization,BP
GO:0061136,5.3159383458282824e-5,0.9999827527370807,21,180,regulation of proteasomal protein catabolic process,BP
GO:0033044,5.325764548595296e-5,0.9999781979025969,31,329,regulation of chromosome organization,BP
GO:0051093,5.351877816873255e-5,0.9999697361086753,71,1022,negative regulation of developmental process,BP
GO:0005543,5.3554982512741056e-5,0.9999758412528614,38,424,phospholipid binding,MF
GO:0043901,5.436102816511244e-5,0.9999829013742313,20,171,negative regulation of multi-organism process,BP
GO:0044451,5.4410629123461106e-5,0.9999684164494147,78,1120,nucleoplasm part,CC
GO:0043434,5.4702742392415506e-5,0.9999752817869754,38,434,response to peptide hormone,BP
GO:0010769,5.570909861010572e-5,0.9999775610206114,30,299,regulation of cell morphogenesis involved in differentiation,BP
GO:0046543,5.6783123734675116e-5,0.9999989454720987,4,6,development of secondary female sexual characteristics,BP
GO:0051347,5.683191843332615e-5,0.9999708776914188,52,649,positive regulation of transferase activity,BP
GO:0006213,5.684669317949391e-5,0.9999906787011743,10,50,pyrimidine nucleoside metabolic process,BP
GO:0097479,5.703187905404405e-5,0.9999820469636059,20,162,synaptic vesicle localization,BP
GO:0017016,5.793807877832707e-5,0.9999737559669308,38,428,Ras GTPase binding,MF
GO:0016197,5.800019820741136e-5,0.999979348274526,24,223,endosomal transport,BP
GO:0071219,5.850876031041134e-5,0.999979693504325,23,211,cellular response to molecule of bacterial origin,BP
GO:0001667,6.004683912638939e-5,0.9999730147376289,37,449,ameboidal-type cell migration,BP
GO:0001932,6.011591271899678e-5,0.9999629205095608,97,1454,regulation of protein phosphorylation,BP
GO:0044437,6.107714849459158e-5,0.9999702433719851,45,549,vacuolar part,CC
GO:0005788,6.170821488039738e-5,0.999974973076709,30,308,endoplasmic reticulum lumen,CC
GO:0030155,6.245958323033982e-5,0.9999677493373665,53,680,regulation of cell adhesion,BP
GO:0000209,6.262383530233824e-5,0.999974580291577,30,308,protein polyubiquitination,BP
GO:0016234,6.368101191506762e-5,0.9999858366840194,13,82,inclusion body,CC
GO:0002088,6.520257987603959e-5,0.9999854939985573,13,80,lens development in camera-type eye,BP
GO:0009411,6.592858574795831e-5,0.9999805357622189,18,141,response to UV,BP
GO:1990778,6.642285139899301e-5,0.9999729381130458,30,311,protein localization to cell periphery,BP
GO:0030198,6.652540443405105e-5,0.9999711647808578,34,368,extracellular matrix organization,BP
GO:0048145,6.680781170110368e-5,0.9999850540632872,13,83,regulation of fibroblast proliferation,BP
GO:0032607,6.74405186048457e-5,0.9999917992393779,8,30,interferon-alpha production,BP
GO:0002191,6.870048680195112e-5,1,3,3,cap-dependent translational initiation,BP
GO:0042177,6.88301139242242e-5,0.9999804726132079,17,130,negative regulation of protein catabolic process,BP
GO:0007264,6.889520046073918e-5,0.999965706181223,47,569,small GTPase mediated signal transduction,BP
GO:0061035,6.89313966183624e-5,0.9999857664843987,12,70,regulation of cartilage development,BP
GO:0032922,7.087699425360365e-5,0.9999865911869243,11,62,circadian regulation of gene expression,BP
GO:0044770,7.121814597312295e-5,0.9999641687029743,48,624,cell cycle phase transition,BP
GO:0051223,7.167078399409368e-5,0.9999626541107811,53,690,regulation of protein transport,BP
GO:0099503,7.211380525102906e-5,0.9999588833298959,70,983,secretory vesicle,CC
GO:0032648,7.25586686171654e-5,0.9999878029828666,10,48,regulation of interferon-beta production,BP
GO:0030879,7.286946964121864e-5,0.9999783123842951,18,141,mammary gland development,BP
GO:0051235,7.500749684317577e-5,0.9999687076644156,31,326,maintenance of location,BP
GO:0019216,7.552819155305648e-5,0.9999661355202134,36,408,regulation of lipid metabolic process,BP
GO:1903320,7.65519548831675e-5,0.9999722209725961,24,226,regulation of protein modification by small protein conjugation or removal,BP
GO:0006612,7.663726119537069e-5,0.999974352062921,21,199,protein targeting to membrane,BP
GO:0015934,7.675127175711148e-5,0.9999800140936906,15,119,large ribosomal subunit,CC
GO:0032103,7.71276357797955e-5,0.999968275499531,30,320,positive regulation of response to external stimulus,BP
GO:0097342,7.723174046934184e-5,0.9999984441996234,4,6,ripoptosome,CC
GO:0000932,7.75998523123707e-5,0.999982356944448,13,84,P-body,CC
GO:0071103,8.168299699636587e-5,0.9999668574543716,29,310,DNA conformation change,BP
GO:0010498,8.258698872152165e-5,0.999961054088368,40,474,proteasomal protein catabolic process,BP
GO:0019218,8.358129130438713e-5,0.9999769545186837,16,124,regulation of steroid metabolic process,BP
GO:0009896,8.381036624316284e-5,0.9999617608454227,37,422,positive regulation of catabolic process,BP
GO:2000278,8.391936158895604e-5,0.9999781024379364,15,108,regulation of DNA biosynthetic process,BP
GO:0061036,8.44164008184198e-5,0.9999892042200209,8,33,positive regulation of cartilage development,BP
GO:0002009,8.581608846560277e-5,0.9999575820826669,45,534,morphogenesis of an epithelium,BP
GO:0098590,8.70669668560437e-5,0.999947468624283,84,1196,plasma membrane region,CC
GO:1902949,8.949916789141649e-5,0.9999974681136916,4,8,positive regulation of tau-protein kinase activity,BP
GO:0031396,8.951949294353067e-5,0.9999688759663737,22,199,regulation of protein ubiquitination,BP
GO:0007520,9.12584757626951e-5,0.9999861074312103,9,41,myoblast fusion,BP
GO:0051241,9.139278055283304e-5,0.999944831959862,84,1286,negative regulation of multicellular organismal process,BP
GO:0007041,9.152214181182157e-5,0.9999759574376548,15,106,lysosomal transport,BP
GO:0043062,9.172210054130526e-5,0.999957958833927,37,422,extracellular structure organization,BP
GO:0044772,9.375460865799476e-5,0.9999533856463223,45,581,mitotic cell cycle phase transition,BP
GO:0050727,9.40686349270593e-5,0.9999578031809271,35,416,regulation of inflammatory response,BP
GO:0034612,9.511929739350054e-5,0.9999610599825217,29,309,response to tumor necrosis factor,BP
GO:1901653,9.720983941942851e-5,0.9999569411690359,34,384,cellular response to peptide,BP
GO:0045860,9.784621061060748e-5,0.9999517364377362,44,532,positive regulation of protein kinase activity,BP
GO:0001822,9.834538949460293e-5,0.9999604723603986,28,277,kidney development,BP
GO:0019882,9.867579964909953e-5,0.9999654169926634,22,204,antigen processing and presentation,BP
GO:0008187,9.899551649004333e-5,0.9999870389784403,8,33,poly-pyrimidine tract binding,MF
GO:0003690,1.0424183339625642e-4,0.9999398409457941,70,951,double-stranded DNA binding,MF
GO:0055085,1.0441890378141223e-4,0.9999334063534634,104,1580,transmembrane transport,BP
GO:0060070,1.0505742271565459e-4,0.9999552973136805,31,332,canonical Wnt signaling pathway,BP
GO:0071560,1.073866528440353e-4,0.9999591344110187,25,248,cellular response to transforming growth factor beta stimulus,BP
GO:1901615,1.0855052853487072e-4,0.9999461973140369,44,534,organic hydroxy compound metabolic process,BP
GO:0034762,1.1190882976348275e-4,0.9999434597591875,46,563,regulation of transmembrane transport,BP
GO:0090087,1.1238986036892695e-4,0.9999398632419113,54,720,regulation of peptide transport,BP
GO:0031267,1.1292622897443946e-4,0.9999470578312507,38,442,small GTPase binding,MF
GO:0000139,1.1297479852521632e-4,0.9999388441752469,56,733,Golgi membrane,CC
GO:0007269,1.1324835138777573e-4,0.9999623876344265,20,168,neurotransmitter secretion,BP
GO:0032508,1.1354877567777515e-4,0.9999695128046547,15,109,DNA duplex unwinding,BP
GO:0071214,1.1518920101671206e-4,0.9999507313541056,31,331,cellular response to abiotic stimulus,BP
GO:0104004,1.1518920101671206e-4,0.9999507313541056,31,331,cellular response to environmental stimulus,BP
GO:2000058,1.152002575308648e-4,0.9999643057115406,18,149,regulation of ubiquitin-dependent protein catabolic process,BP
GO:0008270,1.1530525713339522e-4,0.9999361456933067,60,805,zinc ion binding,MF
GO:0030260,1.161518133340641e-4,0.9999654969639467,17,134,entry into host cell,BP
GO:0044409,1.161518133340641e-4,0.9999654969639467,17,134,entry into host,BP
GO:0051806,1.161518133340641e-4,0.9999654969639467,17,134,entry into cell of other organism involved in symbiotic interaction,BP
GO:0051828,1.161518133340641e-4,0.9999654969639467,17,134,entry into other organism involved in symbiotic interaction,BP
GO:0055086,1.162696237950601e-4,0.999936581022025,57,781,nucleobase-containing small molecule metabolic process,BP
GO:0045596,1.1763907082024052e-4,0.9999365539996684,55,738,negative regulation of cell differentiation,BP
GO:0016485,1.1896784953434431e-4,0.9999533937391801,26,266,protein processing,BP
GO:0032269,1.2120538924622668e-4,0.999928657064875,73,1099,negative regulation of cellular protein metabolic process,BP
GO:0030136,1.2214861249562213e-4,0.9999591051781335,20,176,clathrin-coated vesicle,CC
GO:0043161,1.222139701402826e-4,0.9999437673184239,36,418,proteasome-mediated ubiquitin-dependent protein catabolic process,BP
GO:0099643,1.2374995976279228e-4,0.9999586081104381,20,169,signal release from synapse,BP
GO:0051648,1.2435687785962101e-4,0.9999483000868176,29,303,vesicle localization,BP
GO:0016604,1.2502393642525942e-4,0.9999316201089365,57,775,nuclear body,CC
GO:0072562,1.271010134202553e-4,0.999965378973392,15,116,blood microparticle,CC
GO:0032432,1.2716663057691803e-4,0.9999717985228979,12,74,actin filament bundle,CC
GO:0034599,1.2906283418371323e-4,0.9999471103792251,28,300,cellular response to oxidative stress,BP
GO:0005813,1.293316777202991e-4,0.9999364297566442,42,510,centrosome,CC
GO:0032970,1.298994103623063e-4,0.9999415553441088,34,383,regulation of actin filament-based process,BP
GO:0031647,1.3093871913325846e-4,0.999947348407942,27,278,regulation of protein stability,BP
GO:0045785,1.3095589155744087e-4,0.9999402904616213,35,397,positive regulation of cell adhesion,BP
GO:0003682,1.3200139859783494e-4,0.9999344545489735,43,528,chromatin binding,MF
GO:1990837,1.321494413101142e-4,0.9999246927788349,65,869,sequence-specific double-stranded DNA binding,MF
GO:0021955,1.3221273622647495e-4,0.9999817585147319,8,35,central nervous system neuron axonogenesis,BP
GO:0048675,1.3231588201877294e-4,0.999962077756808,16,120,axon extension,BP
GO:1904951,1.324606981313535e-4,0.9999373624888375,38,451,positive regulation of establishment of protein localization,BP
GO:0120114,1.387090839289727e-4,0.9999686568495961,12,83,Sm-like protein family complex,CC
GO:0006357,1.4314296976238153e-4,0.9998996727380334,161,2652,regulation of transcription by RNA polymerase II,BP
GO:0033674,1.4516777138293564e-4,0.9999257616194553,46,573,positive regulation of kinase activity,BP
GO:0008047,1.4641638430819694e-4,0.9999275808209962,42,517,enzyme activator activity,MF
GO:0035456,1.4697700573283073e-4,0.9999830032913554,7,28,response to interferon-beta,BP
GO:2000052,1.4713922398721914e-4,0.9999912650861009,5,13,positive regulation of non-canonical Wnt signaling pathway,BP
GO:0150034,1.4797417474385322e-4,0.9999389509835931,28,285,distal axon,CC
GO:0030532,1.4845190912117135e-4,0.9999689865534722,11,72,small nuclear ribonucleoprotein complex,CC
GO:0006869,1.486888855608804e-4,0.9999343919289272,32,362,lipid transport,BP
GO:0000792,1.508175068372271e-4,0.9999658451409006,12,76,heterochromatin,CC
GO:0000302,1.5137546311076025e-4,0.9999437217593768,23,228,response to reactive oxygen species,BP
GO:0010657,1.5334814939628146e-4,0.9999647378349479,12,91,muscle cell apoptotic process,BP
GO:0042273,1.551622110440978e-4,0.9999674935801635,11,70,ribosomal large subunit biogenesis,BP
GO:0005518,1.5670836323743975e-4,0.9999672573855729,11,67,collagen binding,MF
GO:0071356,1.5712871539386966e-4,0.9999360083934239,27,288,cellular response to tumor necrosis factor,BP
GO:0007017,1.5912616504027902e-4,0.9999125558806895,56,746,microtubule-based process,BP
GO:0048762,1.5965028573364405e-4,0.9999405270779018,23,218,mesenchymal cell differentiation,BP
GO:0048871,1.6269994316996637e-4,0.999920626194994,40,481,multicellular organismal homeostasis,BP
GO:0007050,1.6394544756356507e-4,0.999937257341531,24,236,cell cycle arrest,BP
GO:0004709,1.6548186388555232e-4,0.9999807606817008,7,26,MAP kinase kinase kinase activity,MF
GO:0030864,1.679458816257964e-4,0.9999584436865417,13,90,cortical actin cytoskeleton,CC
GO:0031099,1.6966678053400688e-4,0.9999398275831156,21,196,regeneration,BP
GO:0061061,1.7095609708210827e-4,0.9999092590005246,50,659,muscle structure development,BP
GO:0071559,1.7152862278247555e-4,0.9999326070321077,25,254,response to transforming growth factor beta,BP
GO:0010608,1.718867854688938e-4,0.9999041983723027,57,1098,posttranscriptional regulation of gene expression,BP
GO:0050852,1.7394876299567515e-4,0.9999400363745219,20,184,T cell receptor signaling pathway,BP
GO:0051129,1.777600612748739e-4,0.9999035260670045,53,723,negative regulation of cellular component organization,BP
GO:0045859,1.8208192523845018e-4,0.9998982671855059,58,788,regulation of protein kinase activity,BP
GO:0002274,1.833518625471375e-4,0.9999029641464288,49,647,myeloid leukocyte activation,BP
GO:0000768,1.8588061950756079e-4,0.9999643642306583,10,54,syncytium formation by plasma membrane fusion,BP
GO:0140253,1.8588061950756079e-4,0.9999643642306583,10,54,cell-cell fusion,BP
GO:0032481,1.8727576083118368e-4,0.9999565173000979,12,77,positive regulation of type I interferon production,BP
GO:0043394,1.8740190096749513e-4,0.9999726456774937,8,36,proteoglycan binding,MF
GO:1901800,1.9100802413729738e-4,0.9999489081206635,14,103,positive regulation of proteasomal protein catabolic process,BP
GO:0032813,1.9849023718872735e-4,0.9999659113657077,9,46,tumor necrosis factor receptor superfamily binding,MF
GO:0062012,1.9871990347367812e-4,0.9999049888258497,37,455,regulation of small molecule metabolic process,BP
GO:0043523,1.997013669978769e-4,0.9999262830768401,22,209,regulation of neuron apoptotic process,BP
GO:0016323,2.0080871083167243e-4,0.9999239838849282,23,217,basolateral plasma membrane,CC
GO:0043025,2.0081825883364388e-4,0.9999000536232495,41,494,neuronal cell body,CC
GO:0070613,2.0249479809996608e-4,0.9999422907234505,15,119,regulation of protein processing,BP
GO:0031331,2.0449266453065698e-4,0.9999081205987963,32,360,positive regulation of cellular catabolic process,BP
GO:0010038,2.0475642425678324e-4,0.999907980792587,32,362,response to metal ion,BP
GO:0042180,2.0487725217941546e-4,0.9999202352884569,24,248,cellular ketone metabolic process,BP
GO:0030665,2.0597779253125951e-4,0.9999444896183627,14,103,clathrin-coated vesicle membrane,CC
GO:0009416,2.0690874113552215e-4,0.9999111855449102,29,313,response to light stimulus,BP
GO:0021954,2.072033312920847e-4,0.9999512976997774,12,78,central nervous system neuron development,BP
GO:1903845,2.0723919726494788e-4,0.9999510995100707,12,82,negative regulation of cellular response to transforming growth factor beta stimulus,BP
GO:0071236,2.09443178263492e-4,0.9999342235901478,17,147,cellular response to antibiotic,BP
GO:0042641,2.107087181009074e-4,0.999950331411081,12,79,actomyosin,CC
GO:0051402,2.112283610028016e-4,0.999917723863911,24,237,neuron apoptotic process,BP
GO:0043269,2.113411885607316e-4,0.9998845499085327,53,693,regulation of ion transport,BP
GO:0050810,2.1204017647533663e-4,0.9999460376949154,13,95,regulation of steroid biosynthetic process,BP
GO:0031901,2.1234487573514987e-4,0.9999333738933431,17,141,early endosome membrane,CC
GO:0097413,2.1380313261139462e-4,0.9999923791235186,4,8,Lewy body,CC
GO:0006417,2.140043406765267e-4,0.9999032626019917,32,410,regulation of translation,BP
GO:0045137,2.1824843220200372e-4,0.9999168600343853,23,219,development of primary sexual characteristics,BP
GO:0002250,2.1844691970714536e-4,0.9998987800628159,34,393,adaptive immune response,BP
GO:1901216,2.236566196484687e-4,0.9999428029791142,13,94,positive regulation of neuron death,BP
GO:0050678,2.2504876013368822e-4,0.9998996146382234,31,366,regulation of epithelial cell proliferation,BP
GO:0010562,2.2645882876283241e-4,0.9998618427160013,77,1132,positive regulation of phosphorus metabolic process,BP
GO:0045937,2.2645882876283241e-4,0.9998618427160013,77,1132,positive regulation of phosphate metabolic process,BP
GO:0070555,2.2727585842494957e-4,0.9999174664162465,21,204,response to interleukin-1,BP
GO:0101031,2.318199760037321e-4,0.9999774437835939,6,21,chaperone complex,CC
GO:0045651,2.3309022606868426e-4,0.9999842625116844,5,14,positive regulation of macrophage differentiation,BP
GO:1903204,2.3601035836154127e-4,0.9999772263338971,6,20,negative regulation of oxidative stress-induced neuron death,BP
GO:0034704,2.376638332956723e-4,0.9999479128732903,11,66,calcium channel complex,CC
GO:1904874,2.3817767292592923e-4,0.9999834715781015,5,15,positive regulation of telomerase RNA localization to Cajal body,BP
GO:0051260,2.4233006930661805e-4,0.9998915757542469,31,349,protein homooligomerization,BP
GO:0003729,2.424835900567421e-4,0.999892217513509,30,475,mRNA binding,MF
GO:0042059,2.443286858190313e-4,0.9999566088975671,9,48,negative regulation of epidermal growth factor receptor signaling pathway,BP
GO:0000791,2.4450016983564656e-4,0.9999692248190122,7,28,euchromatin,CC
GO:0006446,2.476469419890128e-4,0.9999405649706957,12,79,regulation of translational initiation,BP
GO:0008289,2.505584802157644e-4,0.9998612352359075,54,731,lipid binding,MF
GO:0099568,2.5163169896993097e-4,0.9998732859922681,41,505,cytoplasmic region,CC
GO:0004706,2.5248436749862846e-4,0.9999905906901982,4,8,JUN kinase kinase kinase activity,MF
GO:1903317,2.527761065405335e-4,0.9999263569498292,15,121,regulation of protein maturation,BP
GO:0034249,2.5537952527191653e-4,0.9999113642925022,19,215,negative regulation of cellular amide metabolic process,BP
GO:0031625,2.555024127432657e-4,0.9998926264169843,27,290,ubiquitin protein ligase binding,MF
GO:0097305,2.5717473170801947e-4,0.9999006721536814,23,231,response to alcohol,BP
GO:0090261,2.6209558261045717e-4,0.9999972513914446,3,4,positive regulation of inclusion body assembly,BP
GO:0017156,2.625416419456049e-4,0.999912766074629,18,153,calcium ion regulated exocytosis,BP
GO:0032870,2.6323354088978026e-4,0.9998556424712794,52,698,cellular response to hormone stimulus,BP
GO:0030235,2.634063525186613e-4,0.9999900715325327,4,8,nitric-oxide synthase regulator activity,MF
GO:1903844,2.642920461220385e-4,0.999922673708263,15,121,regulation of cellular response to transforming growth factor beta stimulus,BP
GO:0008135,2.69224901880645e-4,0.9999344790960629,12,84,"translation factor activity, RNA binding",MF
GO:0046928,2.6993186041416944e-4,0.999925261815979,14,103,regulation of neurotransmitter secretion,BP
GO:0008610,2.7494350334726235e-4,0.9998489038129402,52,706,lipid biosynthetic process,BP
GO:0032392,2.7750303992127865e-4,0.9999185449786357,15,118,DNA geometric change,BP
GO:0097525,2.798087640495265e-4,0.9999424121328824,10,66,spliceosomal snRNP complex,CC
GO:0044255,2.8027670878035807e-4,0.9998305032861557,72,1064,cellular lipid metabolic process,BP
GO:1904869,2.8119920883072673e-4,0.9999883930656371,4,9,regulation of protein localization to Cajal body,BP
GO:1904871,2.8119920883072673e-4,0.9999883930656371,4,9,positive regulation of protein localization to Cajal body,BP
GO:0003735,2.8498005648039084e-4,0.9999006201255877,19,192,structural constituent of ribosome,MF
GO:0098827,2.863234179350748e-4,0.9998267289152161,72,1057,endoplasmic reticulum subcompartment,CC
GO:1901739,2.891858488507153e-4,0.9999706552322059,6,21,regulation of myoblast fusion,BP
GO:0046596,2.9299759239354744e-4,0.9999615281269012,7,30,regulation of viral entry into host cell,BP
GO:0010565,2.9557261823701597e-4,0.9998968654606266,19,181,regulation of cellular ketone metabolic process,BP
GO:0006470,2.9721259552397273e-4,0.9998694535879424,29,319,protein dephosphorylation,BP
GO:0051015,2.972144969958673e-4,0.9998899710127889,21,198,actin filament binding,MF
GO:0043393,2.9963683336534737e-4,0.9998858849913034,22,216,regulation of protein binding,BP
GO:0016581,3.0257257822609686e-4,0.9999778633734068,5,15,NuRD complex,CC
GO:0090545,3.0257257822609686e-4,0.9999778633734068,5,15,CHD-type complex,CC
GO:0097296,3.0355359892529095e-4,0.9999966497662216,3,4,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP
GO:0031330,3.052710021020573e-4,0.9998751496185497,25,262,negative regulation of cellular catabolic process,BP
GO:0032651,3.132235530368871e-4,0.999922097026387,12,90,regulation of interleukin-1 beta production,BP
GO:0032652,3.146910051639998e-4,0.9999161299004843,13,102,regulation of interleukin-1 production,BP
GO:0032647,3.1470196384794505e-4,0.9999586700532122,7,28,regulation of interferon-alpha production,BP
GO:2000106,3.1555975904608513e-4,0.9999218902712568,12,83,regulation of leukocyte apoptotic process,BP
GO:0046332,3.1664490392959273e-4,0.9999218061529259,12,80,SMAD binding,MF
GO:0006457,3.176254602665741e-4,0.9998784032279772,22,221,protein folding,BP
GO:0009117,3.22327504082638e-4,0.9998237692572584,50,689,nucleotide metabolic process,BP
GO:0006397,3.2559305632650135e-4,0.9998352900746171,40,507,mRNA processing,BP
GO:0004672,3.2609410585529764e-4,0.9998266565635107,46,590,protein kinase activity,MF
GO:0051147,3.27577489930293e-4,0.9998883408297664,18,178,regulation of muscle cell differentiation,BP
GO:0032434,3.2979782418430354e-4,0.9999013906100676,15,122,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP
GO:0000226,3.326104079912086e-4,0.9998271079507913,43,547,microtubule cytoskeleton organization,BP
GO:0043405,3.340161100666956e-4,0.999849874987101,30,335,regulation of MAP kinase activity,BP
GO:0042578,3.3639508918173016e-4,0.9998443249881442,32,366,phosphoric ester hydrolase activity,MF
GO:1900182,3.383198231953126e-4,0.9999219142102249,11,74,positive regulation of protein localization to nucleus,BP
GO:0032535,3.4518556749073905e-4,0.9998399896485444,32,368,regulation of cellular component size,BP
GO:0009792,3.5165340183131426e-4,0.9998083385370735,49,639,embryo development ending in birth or egg hatching,BP
GO:0030099,3.5426374549414423e-4,0.9998311082848595,34,412,myeloid cell differentiation,BP
GO:0009116,3.552173602885158e-4,0.9998930747450244,15,121,nucleoside metabolic process,BP
GO:0071478,3.5667040180462864e-4,0.9998697080605522,20,191,cellular response to radiation,BP
GO:0006906,3.5667765580649257e-4,0.9999041630480278,13,94,vesicle fusion,BP
GO:1901135,3.588314237554988e-4,0.9997745978107455,81,1242,carbohydrate derivative metabolic process,BP
GO:1902803,3.591907357079862e-4,0.9999097822344256,12,83,regulation of synaptic vesicle transport,BP
GO:0030687,3.6122482959218135e-4,0.9999610009930969,6,23,"preribosome, large subunit precursor",CC
GO:0051272,3.629236373106075e-4,0.9998103112918749,43,580,positive regulation of cellular component movement,BP
GO:0051082,3.630348736335924e-4,0.999890251292612,15,126,unfolded protein binding,MF
GO:0045089,3.6328177676155543e-4,0.9998309942146433,32,376,positive regulation of innate immune response,BP
GO:0043202,3.634891755520106e-4,0.9999020665640629,13,95,lysosomal lumen,CC
GO:1903202,3.658405988559869e-4,0.9999302071173943,9,56,negative regulation of oxidative stress-induced cell death,BP
GO:0006403,3.6754958806117387e-4,0.9998575851130047,22,228,RNA localization,BP
GO:0008406,3.6819363321636227e-4,0.9998576749833098,22,213,gonad development,BP
GO:1902187,3.6895968517190535e-4,0.9999717914549089,5,15,negative regulation of viral release from host cell,BP
GO:0010212,3.68980486920592e-4,0.9998782034878106,17,147,response to ionizing radiation,BP
GO:0000151,3.719221544904108e-4,0.9998426351267031,26,282,ubiquitin ligase complex,CC
GO:0016079,3.759688619077861e-4,0.9998863647522366,15,118,synaptic vesicle exocytosis,BP
GO:1904813,3.7632199458331956e-4,0.9998859351887694,15,124,ficolin-1-rich granule lumen,CC
GO:0042327,3.787652040313051e-4,0.999768420134687,72,1061,positive regulation of phosphorylation,BP
GO:0033209,3.803687578568392e-4,0.9998691048105973,18,165,tumor necrosis factor-mediated signaling pathway,BP
GO:0005874,3.8088246243324385e-4,0.9998156324706822,35,415,microtubule,CC
GO:0031401,3.819194673253987e-4,0.9997595121584278,81,1228,positive regulation of protein modification process,BP
GO:0030177,3.831255382806219e-4,0.9998634961594222,19,179,positive regulation of Wnt signaling pathway,BP
GO:0010660,3.850560995598009e-4,0.9999087039865094,11,87,regulation of muscle cell apoptotic process,BP
GO:1900408,3.873604628685973e-4,0.9999253916131905,9,57,negative regulation of cellular response to oxidative stress,BP
GO:0007565,3.887475619137805e-4,0.9998570402892981,20,190,female pregnancy,BP
GO:2000050,3.935043003472568e-4,0.9999568142878443,6,23,regulation of non-canonical Wnt signaling pathway,BP
GO:0060996,3.9982560389141704e-4,0.9998910975076046,13,96,dendritic spine development,BP
GO:0098772,4.025295160144945e-4,0.9997288721527565,110,1799,molecular function regulator,MF
GO:0006753,4.03536313823979e-4,0.9997770823483798,50,696,nucleoside phosphate metabolic process,BP
GO:0031100,4.0551005069846717e-4,0.9999045483102152,11,72,animal organ regeneration,BP
GO:0001934,4.065791329764235e-4,0.9997534477079035,69,1010,positive regulation of protein phosphorylation,BP
GO:0070925,4.13438881222982e-4,0.9997595736301332,59,837,organelle assembly,BP
GO:0005789,4.212764030420337e-4,0.999742291552106,71,1053,endoplasmic reticulum membrane,CC
GO:0060026,4.2173896161426424e-4,0.9999667812448683,5,15,convergent extension,BP
GO:0050808,4.217910942691011e-4,0.9997947537331614,35,407,synapse organization,BP
GO:0000976,4.235248159683529e-4,0.9997525406338014,60,820,transcription regulatory region sequence-specific DNA binding,MF
GO:0030135,4.319426121337668e-4,0.9998188979025626,25,269,coated vesicle,CC
GO:0010821,4.320129624513689e-4,0.9998444657652854,19,181,regulation of mitochondrion organization,BP
GO:0072331,4.366131597531821e-4,0.999816846390486,25,267,signal transduction by p53 class mediator,BP
GO:0044706,4.406222791885736e-4,0.9998271465018866,22,220,multi-multicellular organism process,BP
GO:0098793,4.4258741221608986e-4,0.9997726405731883,40,490,presynapse,CC
GO:1990000,4.436427140592671e-4,0.9999639869928596,5,16,amyloid fibril formation,BP
GO:0048285,4.482946018136548e-4,0.9997783422330737,36,447,organelle fission,BP
GO:0044294,4.492584638920968e-4,0.9999789644655603,4,9,dendritic growth cone,CC
GO:0071363,4.592250337321739e-4,0.9997432158779183,51,698,cellular response to growth factor stimulus,BP
GO:0042175,4.5937880142315926e-4,0.9997170699977467,72,1075,nuclear outer membrane-endoplasmic reticulum membrane network,CC
GO:0097191,4.597900300130176e-4,0.9998189553164276,22,223,extrinsic apoptotic signaling pathway,BP
GO:0034765,4.6182741008646245e-4,0.999764392371204,39,478,regulation of ion transmembrane transport,BP
GO:0007179,4.710559078192288e-4,0.999823790267889,20,198,transforming growth factor beta receptor signaling pathway,BP
GO:0051493,4.7994357138293785e-4,0.9997499642276252,41,527,regulation of cytoskeleton organization,BP
GO:0061684,4.8412943761475474e-4,0.9999599263125059,5,16,chaperone-mediated autophagy,BP
GO:0002183,4.8825386078608815e-4,0.9999287833265531,7,34,cytoplasmic translational initiation,BP
GO:0005815,4.898825352726793e-4,0.9997219380019119,53,734,microtubule organizing center,CC
GO:1903405,4.917659550691006e-4,0.9999751424665995,4,10,protein localization to nuclear body,BP
GO:1904851,4.917659550691006e-4,0.9999751424665995,4,10,positive regulation of establishment of protein localization to telomere,BP
GO:1904867,4.917659550691006e-4,0.9999751424665995,4,10,protein localization to Cajal body,BP
GO:0006958,4.927620330142512e-4,0.9999280131429749,7,34,"complement activation, classical pathway",BP
GO:1901185,4.950922840813532e-4,0.9999019726966798,9,53,negative regulation of ERBB signaling pathway,BP
GO:1901215,4.993739465389745e-4,0.9998072408538293,21,206,negative regulation of neuron death,BP
GO:0004674,5.085298087437007e-4,0.9997469003724987,36,437,protein serine/threonine kinase activity,MF
GO:1903364,5.095515361105739e-4,0.9998334499619059,16,139,positive regulation of cellular protein catabolic process,BP
GO:0048167,5.13157349974236e-4,0.999807145161357,20,187,regulation of synaptic plasticity,BP
GO:1902883,5.219257915173692e-4,0.999894870315659,9,59,negative regulation of response to oxidative stress,BP
GO:0031264,5.269585742819489e-4,0.9999742369893511,4,9,death-inducing signaling complex,CC
GO:1990234,5.351355394749088e-4,0.9996917276889107,55,777,transferase complex,CC
GO:0000165,5.396048260028718e-4,0.9996742121225872,65,952,MAPK cascade,BP
GO:0009986,5.499740582927102e-4,0.9996779896137865,58,804,cell surface,CC
GO:0051427,5.507493215663045e-4,0.9997975178166176,19,184,hormone receptor binding,MF
GO:0033227,5.567585148109348e-4,0.999988873439825,3,5,dsRNA transport,BP
GO:0006066,5.615638725066578e-4,0.9997353512308039,31,363,alcohol metabolic process,BP
GO:0048284,5.673493500872816e-4,0.9998209958267837,15,124,organelle fusion,BP
GO:0017158,5.74711422087956e-4,0.9998273615558703,14,111,regulation of calcium ion-dependent exocytosis,BP
GO:0050772,5.808886193336498e-4,0.9998456127776575,12,85,positive regulation of axonogenesis,BP
GO:0030425,5.843409058699513e-4,0.9996780319059344,47,618,dendrite,CC
GO:2001234,5.866643943014916e-4,0.9997644467568655,22,229,negative regulation of apoptotic signaling pathway,BP
GO:0000987,5.867547915312571e-4,0.9996861821284879,43,543,proximal promoter sequence-specific DNA binding,MF
GO:0040012,5.940590230382643e-4,0.9996353915978077,68,1061,regulation of locomotion,BP
GO:0051054,5.946681208436412e-4,0.9997610211719123,22,228,positive regulation of DNA metabolic process,BP
GO:0097039,6.035998796387672e-4,0.9999875915285271,3,5,protein linear polyubiquitination,BP
GO:0035637,6.072944602561283e-4,0.9997621643916118,21,201,multicellular organismal signaling,BP
GO:0000784,6.084745125995899e-4,0.9998152780833722,14,121,"nuclear chromosome, telomeric region",CC
GO:0075522,6.109672590333943e-4,0.9999672473531167,4,10,IRES-dependent viral translational initiation,BP
GO:0044003,6.201320339823422e-4,0.9998880316772373,8,46,modification by symbiont of host morphology or physiology,BP
GO:0034504,6.247647683057426e-4,0.9997363056049601,24,261,protein localization to nucleus,BP
GO:0097447,6.283182905726687e-4,0.999652563517447,47,620,dendritic tree,CC
GO:1904872,6.288304534711297e-4,0.9999431441312104,5,18,regulation of telomerase RNA localization to Cajal body,BP
GO:0030512,6.439257374668481e-4,0.999838388882151,11,80,negative regulation of transforming growth factor beta receptor signaling pathway,BP
GO:0007034,6.51655028630134e-4,0.999781849164154,16,141,vacuolar transport,BP
GO:0048872,6.543053563351307e-4,0.999728830458712,23,245,homeostasis of number of cells,BP
GO:0071902,6.550411154632944e-4,0.999697059119545,29,334,positive regulation of protein serine/threonine kinase activity,BP
GO:0101002,6.577459505081042e-4,0.9997544781004148,19,185,ficolin-1-rich granule,CC
GO:0006302,6.631411552464714e-4,0.99972485552206,23,246,double-strand break repair,BP
GO:0043565,6.669685564694285e-4,0.9995779260004348,76,1118,sequence-specific DNA binding,MF
GO:0032956,6.680021814776762e-4,0.9996905725722788,29,338,regulation of actin cytoskeleton organization,BP
GO:0051588,6.729734450056827e-4,0.9997742556161862,16,138,regulation of neurotransmitter transport,BP
GO:0000280,6.772906098176145e-4,0.999668467756299,33,407,nuclear division,BP
GO:0090174,6.865987167616826e-4,0.9998011904204656,13,100,organelle membrane fusion,BP
GO:2000573,6.882042510938679e-4,0.9998406336651758,10,67,positive regulation of DNA biosynthetic process,BP
GO:2001235,6.935343503565413e-4,0.9997478793132336,18,176,positive regulation of apoptotic signaling pathway,BP
GO:0007265,6.958911766516691e-4,0.9996472846637134,36,446,Ras protein signal transduction,BP
GO:0045926,6.994053924137722e-4,0.9997086089372358,23,247,negative regulation of growth,BP
GO:0070848,7.023915083024543e-4,0.9995969783226123,52,727,response to growth factor,BP
GO:0030141,7.049687759801831e-4,0.9995844824967912,57,831,secretory granule,CC
GO:0150011,7.062452383203233e-4,0.9999606179174796,4,10,regulation of neuron projection arborization,BP
GO:0006335,7.07253638706047e-4,0.9999087896370595,6,31,DNA replication-dependent nucleosome assembly,BP
GO:0034723,7.07253638706047e-4,0.9999087896370595,6,31,DNA replication-dependent nucleosome organization,BP
GO:0017015,7.090620534795461e-4,0.9997814835517295,14,119,regulation of transforming growth factor beta receptor signaling pathway,BP
GO:0070203,7.153350998438064e-4,0.9999583811302506,4,11,regulation of establishment of protein localization to telomere,BP
GO:0043621,7.160525954808654e-4,0.9998500882256803,9,55,protein self-association,MF
GO:0046649,7.225419978312012e-4,0.9995948525309991,48,656,lymphocyte activation,BP
GO:0072332,7.275910816037412e-4,0.9998149511607968,11,78,intrinsic apoptotic signaling pathway by p53 class mediator,BP
GO:0023061,7.298871609915465e-4,0.9996253024370909,37,459,signal release,BP
GO:0019049,7.331852483919422e-4,0.9999838635803339,3,5,evasion or tolerance of host defenses by virus,BP
GO:0044413,7.331852483919422e-4,0.9999838635803339,3,5,avoidance of host defenses,BP
GO:0044415,7.331852483919422e-4,0.9999838635803339,3,5,evasion or tolerance of host defenses,BP
GO:0051832,7.331852483919422e-4,0.9999838635803339,3,5,avoidance of defenses of other organism involved in symbiotic interaction,BP
GO:0051834,7.331852483919422e-4,0.9999838635803339,3,5,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP
GO:0023014,7.345355977121217e-4,0.9995508015540141,65,963,signal transduction by protein phosphorylation,BP
GO:0061448,7.354954769414625e-4,0.9996797483146794,25,271,connective tissue development,BP
GO:0044463,7.448266421424554e-4,0.999505205829889,93,1459,cell projection part,CC
GO:0120038,7.448266421424554e-4,0.999505205829889,93,1459,plasma membrane bounded cell projection part,CC
GO:0050729,7.449324299298833e-4,0.9997467155713401,16,150,positive regulation of inflammatory response,BP
GO:0002758,7.462084186923772e-4,0.99966833747139106,26,296,innate immune response-activating signal transduction,BP
GO:0010256,7.46265322890153e-4,0.99962416079078,35,435,endomembrane system organization,BP
GO:0007610,7.472956154195476e-4,0.999589028799287,45,592,behavior,BP
GO:0006338,7.482899739677342e-4,0.9997260242315058,18,178,chromatin remodeling,BP
GO:0007568,7.527449706862662e-4,0.9996593436602972,27,313,aging,BP
GO:0005123,7.531367683456191e-4,0.9999300449354833,5,17,death receptor binding,MF
GO:0042695,7.545707525523069e-4,0.9999832242655258,3,5,thelarche,BP
GO:0060744,7.545707525523069e-4,0.9999832242655258,3,5,mammary gland branching involved in thelarche,BP
GO:0001649,7.546867814716894e-4,0.9996984361954627,21,217,osteoblast differentiation,BP
GO:0006836,7.574762680090146e-4,0.9996695957730956,25,268,neurotransmitter transport,BP
GO:1990138,7.655491099171012e-4,0.9997198690766711,18,167,neuron projection extension,BP
GO:1903265,7.669000154680919e-4,0.9999562640828344,4,10,positive regulation of tumor necrosis factor-mediated signaling pathway,BP
GO:0005522,7.759800349507867e-4,0.9999538418103396,4,11,profilin binding,MF
GO:0002224,7.776136188939612e-4,0.9997348364113969,16,146,toll-like receptor signaling pathway,BP
GO:0075525,7.828989073046742e-4,0.9999823674277779,3,5,viral translational termination-reinitiation,BP
GO:0005774,7.883684118892808e-4,0.9996152123521174,32,394,vacuolar membrane,CC
GO:0050806,7.931081563130294e-4,0.9997088012908933,18,168,positive regulation of synaptic transmission,BP
GO:0060968,0.00079311915921445055,0.9997397723521341,15,140,regulation of gene silencing,BP
GO:0006898,7.981360135415572e-4,0.9996638088786299,23,255,receptor-mediated endocytosis,BP
GO:0051047,8.017855512630305e-4,0.9995988845690106,34,423,positive regulation of secretion,BP
GO:0060751,8.079914024326096e-4,0.999981599153832,3,5,branch elongation involved in mammary gland duct branching,BP
GO:0032594,8.088360111247891e-4,0.9998713404560453,7,34,protein transport within lipid bilayer,BP
GO:0032552,8.096718891786869e-4,0.9999815473934036,3,5,deoxyribonucleotide binding,MF
GO:0008630,8.098415518228955e-4,0.9997606589313748,13,104,intrinsic apoptotic signaling pathway in response to DNA damage,BP
GO:0045185,8.20630221281142e-4,0.9997569841095434,13,105,maintenance of protein location,BP
GO:0030308,8.207520487291905e-4,0.9996877331584049,19,186,negative regulation of cell growth,BP
GO:0048568,8.211970905058269e-4,0.9995843308967584,35,425,embryonic organ development,BP
GO:0046661,8.222705821242785e-4,0.9997073595098025,17,156,male sex differentiation,BP
GO:0019637,8.306675405507502e-4,0.9994728506065944,74,1154,organophosphate metabolic process,BP
GO:0045787,8.314394211011228e-4,0.9995978416103548,31,386,positive regulation of cell cycle,BP
GO:0001968,8.329779055893528e-4,0.9998912734203017,6,27,fibronectin binding,MF
GO:0051270,8.358009871009068e-4,0.9994799131552644,68,1072,regulation of cellular component movement,BP
GO:1903052,8.404064162319637e-4,0.9997363620457566,14,119,positive regulation of proteolysis involved in cellular protein catabolic process,BP
GO:0010954,8.423942200160122e-4,0.9998886223994277,6,29,positive regulation of protein processing,BP
GO:0032092,8.44221845361647e-4,0.9997643098461968,12,93,positive regulation of protein binding,BP
GO:0060330,8.44258900222067e-4,0.9998909061067489,6,25,regulation of response to interferon-gamma,BP
GO:0060334,8.44258900222067e-4,0.9998909061067489,6,25,regulation of interferon-gamma-mediated signaling pathway,BP
GO:0051604,8.512959708365293e-4,0.999604998824785,28,335,protein maturation,BP
GO:0071706,8.605184066577867e-4,0.9996915814748454,17,167,tumor necrosis factor superfamily cytokine production,BP
GO:0051020,8.620779268091283e-4,0.999536575288562,41,540,GTPase binding,MF
GO:0090670,8.634237726982434e-4,0.9999151477715943,5,19,RNA localization to Cajal body,BP
GO:0090671,8.634237726982434e-4,0.9999151477715943,5,19,telomerase RNA localization to Cajal body,BP
GO:0090672,8.634237726982434e-4,0.9999151477715943,5,19,telomerase RNA localization,BP
GO:0090685,8.634237726982434e-4,0.9999151477715943,5,19,RNA localization to nucleus,BP
GO:0032436,8.677799507045934e-4,0.9997738407077771,11,81,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP
GO:0001725,8.724705338421862e-4,0.9997915127394209,10,67,stress fiber,CC
GO:0097517,8.724705338421862e-4,0.9997915127394209,10,67,contractile actin filament bundle,CC
GO:0030111,8.734054463025141e-4,0.9995821718602587,30,360,regulation of Wnt signaling pathway,BP
GO:0004527,8.747430752542341e-4,0.9997719907611163,11,80,exonuclease activity,MF
GO:0006665,8.765497008663362e-4,0.9996860234323688,17,158,sphingolipid metabolic process,BP
GO:0150063,8.808714031140882e-4,0.9995729364112854,31,366,visual system development,BP
GO:0014916,8.980634420165328e-4,0.9999748322679409,3,6,regulation of lung blood pressure,BP
GO:0030662,8.996428303286197e-4,0.9996766347641077,17,162,coated vesicle membrane,CC
GO:0031983,9.056041633153065e-4,0.9995779205233636,28,339,vesicle lumen,CC
GO:0060828,9.057414118044467e-4,0.9995991531348875,25,283,regulation of canonical Wnt signaling pathway,BP
GO:0036465,9.066441910363714e-4,0.9997819857270017,10,68,synaptic vesicle recycling,BP
GO:0008637,9.097398800617077e-4,0.9997117428779898,14,123,apoptotic mitochondrial changes,BP
GO:1903201,9.101379117809684e-4,0.9997794830463435,10,75,regulation of oxidative stress-induced cell death,BP
GO:0043687,9.116713749429256e-4,0.9995626274095614,30,361,post-translational protein modification,BP
GO:0090066,9.140573519021436e-4,0.9995155595188405,39,502,regulation of anatomical structure size,BP
GO:0046165,9.214790508214513e-4,0.9996566333036616,18,174,alcohol biosynthetic process,BP
GO:1903532,9.315600140829508e-4,0.9995406035225597,32,394,positive regulation of secretion by cell,BP
GO:1902041,9.317198517469071e-4,0.9997964867094636,9,58,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP
GO:1902903,9.401662980580815e-4,0.9995543460903024,29,347,regulation of supramolecular fiber organization,BP
GO:0090201,9.422542998283851e-4,0.9999055497893872,5,19,negative regulation of release of cytochrome c from mitochondria,BP
GO:0051668,9.425033586181546e-4,0.9996724198737134,16,148,localization within membrane,BP
GO:2001269,9.537036166908439e-4,0.9999399838291481,4,11,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP
GO:0060589,9.564547106779835e-4,0.9995462456864906,29,343,nucleoside-triphosphatase regulator activity,MF
GO:0005509,9.591741183437941e-4,0.9994448894935839,51,701,calcium ion binding,MF
GO:0002218,9.638209409861551e-4,0.9995562046135492,27,317,activation of innate immune response,BP
GO:0001836,9.748607765216195e-4,0.9997853631692455,9,59,release of cytochrome c from mitochondria,BP
GO:1900019,9.795653432750533e-4,0.9999761243754036,3,5,regulation of protein kinase C activity,BP
GO:1900020,9.795653432750533e-4,0.9999761243754036,3,5,positive regulation of protein kinase C activity,BP
GO:0034644,9.79824098651039e-4,0.999740536446171,11,82,cellular response to UV,BP
GO:0043112,9.806429149967824e-4,0.9996206904611923,19,192,receptor metabolic process,BP
GO:1903203,9.820379236281068e-4,0.9998684158830092,6,26,regulation of oxidative stress-induced neuron death,BP
GO:0032612,9.886589195172608e-4,0.9996998057220231,13,114,interleukin-1 production,BP
GO:0032611,9.939378292913648e-4,0.9997158012615021,12,101,interleukin-1 beta production,BP
GO:0060749,0.0010086764859838057,0.9998985212081901,5,18,mammary gland alveolus development,BP
GO:0061377,0.0010086764859838057,0.9998985212081901,5,18,mammary gland lobule development,BP
GO:0009306,0.0010089038520968967,0.9994441981852107,43,586,protein secretion,BP
GO:0022616,0.001015254331747753,0.9998622446936909,6,27,DNA strand elongation,BP
GO:0043044,0.001020992800852442,0.999727219995831,11,87,ATP-dependent chromatin remodeling,BP
GO:0035196,0.0010242301543646522,0.9997999901576615,8,46,production of miRNAs involved in gene silencing by miRNA,BP
GO:0031967,0.0010252205369011478,0.9993459294874589,73,1158,organelle envelope,CC
GO:0031975,0.0010252205369011478,0.9993459294874589,73,1158,envelope,CC
GO:1901987,0.0010291784068269525,0.9994708163500657,35,474,regulation of cell cycle phase transition,BP
GO:0097237,0.0010294182965325353,0.9995672103332307,22,246,cellular response to toxic substance,BP
GO:0016504,0.0010306703696346027,0.9998271644262496,7,37,peptidase activator activity,MF
GO:0010803,0.0010307065529550003,0.9997712357065174,9,59,regulation of tumor necrosis factor-mediated signaling pathway,BP
GO:0048193,0.0010340354275898615,0.9994996547774029,30,367,Golgi vesicle transport,BP
GO:0031098,0.001036360175740656,0.9995205650317827,27,313,stress-activated protein kinase signaling cascade,BP
GO:0045652,0.0010379598360837354,0.9997438386854766,10,76,regulation of megakaryocyte differentiation,BP
GO:0099632,0.001040702626588853,0.999858955369005,6,26,protein transport within plasma membrane,BP
GO:0099637,0.001040702626588853,0.999858955369005,6,26,neurotransmitter receptor transport,BP
GO:0030335,0.0010438540563017782,0.9994418647063659,39,541,positive regulation of cell migration,BP
GO:0003714,0.0010442190763253253,0.9995609508125404,22,238,transcription corepressor activity,MF
GO:0005891,0.00105254505308898,0.9997950491338994,8,43,voltage-gated calcium channel complex,CC
GO:1903829,0.0010652744833445531,0.9995058724282033,27,322,positive regulation of cellular protein localization,BP
GO:0048306,0.0010655693911945372,0.9997617157642205,9,61,calcium-dependent protein binding,MF
GO:0032182,0.001067708302126243,0.9996930075320265,12,96,ubiquitin-like protein binding,MF
GO:1905288,0.0010729051029819932,0.9999263634486707,4,13,vascular associated smooth muscle cell apoptotic process,BP
GO:1905459,0.0010729051029819932,0.9999263634486707,4,13,regulation of vascular associated smooth muscle cell apoptotic process,BP
GO:0070202,0.0010745293132975093,0.9999279892307305,4,12,regulation of establishment of protein localization to chromosome,BP
GO:0048066,0.0010803835824623402,0.9997867801344168,8,47,developmental pigmentation,BP
GO:1904816,0.0010969516417913446,0.9999260692028874,4,12,"positive regulation of protein localization to chromosome, telomeric region",BP
GO:0048880,0.0011051387772626903,0.999456236179634,31,371,sensory system development,BP
GO:0051052,0.0011146831521206598,0.999437261895482,33,417,regulation of DNA metabolic process,BP
GO:0043009,0.00111842261765979,0.9993675023049787,46,622,chordate embryonic development,BP
GO:1990173,0.0011188355331104498,0.9999241846643427,4,12,protein localization to nucleoplasm,BP
GO:0061337,0.0011189950304503467,0.9996051608951338,16,143,cardiac conduction,BP
GO:2000059,0.0011452143463147855,0.999771424819862,8,48,negative regulation of ubiquitin-dependent protein catabolic process,BP
GO:0090181,0.0011483567857195804,0.999739755525238,9,63,regulation of cholesterol metabolic process,BP
GO:0019048,0.0011497498996432636,0.999802288175399,7,39,modulation by virus of host morphology or physiology,BP
GO:0070169,0.0011556349121576975,0.9997694869480709,8,47,positive regulation of biomineral tissue development,BP
GO:0030855,0.0011569795120576012,0.999331868999571,49,682,epithelial cell differentiation,BP
GO:0060338,0.0011575944410886405,0.9998032502169091,7,35,regulation of type I interferon-mediated signaling pathway,BP
GO:0005791,0.0011590540959999676,0.9996858238451966,11,85,rough endoplasmic reticulum,CC
GO:0046718,0.001163235287272088,0.9996220051217801,14,121,viral entry into host cell,BP
GO:0034250,0.0011751963676202564,0.999582347091999,16,151,positive regulation of cellular amide metabolic process,BP
GO:0008253,0.0012014094149388629,0.999916981748364,4,12,5'-nucleotidase activity,MF
GO:0035257,0.0012049979695617048,0.9995707083874295,16,151,nuclear hormone receptor binding,MF
GO:0044843,0.0012062544295441773,0.9994638092692859,24,291,cell cycle G1/S phase transition,BP
GO:0007256,0.0012117977026087762,0.9999185581180164,4,11,activation of JNKK activity,BP
GO:0045765,0.0012148559746681348,0.9994293937565764,27,370,regulation of angiogenesis,BP
GO:0036475,0.0012191304836879579,0.9998285063527873,6,27,neuron death in response to oxidative stress,BP
GO:2000108,0.001220817875576176,0.999827275850525,6,28,positive regulation of leukocyte apoptotic process,BP
GO:0016358,0.0012211359561607885,0.9994805887644231,22,232,dendrite development,BP
GO:0003743,0.0012459897522697208,0.9997465510445275,8,51,translation initiation factor activity,MF
GO:0070087,0.0012471316216296163,0.999960763013161,3,6,chromo shadow domain binding,MF
GO:1902947,0.0012472754634434368,0.9999107880216335,4,13,regulation of tau-protein kinase activity,BP
GO:0051150,0.0012548026073112028,0.9997772614729084,7,46,regulation of smooth muscle cell differentiation,BP
GO:0070382,0.0012551706987547159,0.9994901456847499,20,206,exocytic vesicle,CC
GO:0004842,0.001264990482915426,0.9993717162012457,31,382,ubiquitin-protein transferase activity,MF
GO:0050853,0.0012652364782065704,0.9997099263418339,9,61,B cell receptor signaling pathway,BP
GO:0002244,0.0012674665836975244,0.999529162211714,17,166,hematopoietic progenitor cell differentiation,BP
GO:0048260,0.0012681422666894796,0.9997417824096384,8,50,positive regulation of receptor-mediated endocytosis,BP
GO:0035567,0.0012701490079795996,0.9995452910972106,16,150,non-canonical Wnt signaling pathway,BP
GO:0019042,0.001272356130679283,0.9999133309353074,4,11,viral latency,BP
GO:0008584,0.0012750291429635967,0.9995619839068709,15,134,male gonad development,BP
GO:1901617,0.001284836813096206,0.9994273619605555,24,270,organic hydroxy compound biosynthetic process,BP
GO:0007167,0.0012858597114156888,0.9991860858683655,68,1036,enzyme linked receptor protein signaling pathway,BP
GO:0034220,0.0012889449109052809,0.9991632248533479,76,1164,ion transmembrane transport,BP
GO:2000379,0.0012890326210311346,0.9996207837507496,12,97,positive regulation of reactive oxygen species metabolic process,BP
GO:0043001,0.0012976388492210954,0.9997720744290766,7,39,Golgi to plasma membrane protein transport,BP
GO:0072527,0.0013182074452628098,0.9996111666579092,12,97,pyrimidine-containing compound metabolic process,BP
GO:0071074,0.0013317825194215547,1,2,2,eukaryotic initiation factor eIF2 binding,MF
GO:0002443,0.0013355298429202338,0.9992096107817953,52,761,leukocyte mediated immunity,BP
GO:2000147,0.0013374447779804753,0.9992686417024055,40,565,positive regulation of cell motility,BP
GO:0031012,0.0013376446059439613,0.9992695054550024,40,526,extracellular matrix,CC
GO:2001238,0.0013475821982147432,0.9997234578597446,8,49,positive regulation of extrinsic apoptotic signaling pathway,BP
GO:1901998,0.0013543817913067432,0.9997603110148234,7,39,toxin transport,BP
GO:1903319,0.001355020847832966,0.9998015361541431,6,31,positive regulation of protein maturation,BP
GO:0046546,0.001361635086211395,0.999528912038088,15,135,development of primary male sexual characteristics,BP
GO:0044212,0.0013677467733732547,0.999144940852298,64,934,transcription regulatory region DNA binding,MF
GO:0000470,0.0013694457534032755,0.9998475776759558,5,21,maturation of LSU-rRNA,BP
GO:0045351,0.0013701902728967812,0.9999047380861208,4,11,type I interferon biosynthetic process,BP
GO:0098644,0.0013735001044443973,0.9998499637030327,5,19,complex of collagen trimers,CC
GO:0045732,0.0013773859363259344,0.9994354291031365,20,213,positive regulation of protein catabolic process,BP
GO:0050817,0.001399348089721507,0.9993281241239472,28,340,coagulation,BP
GO:0006271,0.0014046092648411792,0.9998441796277625,5,20,DNA strand elongation involved in DNA replication,BP
GO:0001067,0.0014063709325889944,0.9991197371878798,64,935,regulatory region nucleic acid binding,MF
GO:0002263,0.0014087801810068023,0.9991780680377371,49,706,cell activation involved in immune response,BP
GO:0055038,0.001423011208412974,0.9996345578139668,10,73,recycling endosome membrane,CC
GO:1901741,0.0014262676424419349,0.9998428451918397,5,19,positive regulation of myoblast fusion,BP
GO:0016064,0.0014429143400432258,0.9995431116914493,13,113,immunoglobulin mediated immune response,BP
GO:0140014,0.0014648115623139037,0.9993528645674362,23,264,mitotic nuclear division,BP
GO:0001736,0.0014750482603116952,0.9995077360472603,14,124,establishment of planar polarity,BP
GO:0007164,0.0014750482603116952,0.9995077360472603,14,124,establishment of tissue polarity,BP
GO:0034698,0.001491154487407049,0.9997804928109301,6,28,response to gonadotropin,BP
GO:0000819,0.0015036469170428034,0.9994126729722773,18,188,sister chromatid segregation,BP
GO:0032482,0.0015048844503304216,0.9996102222982978,10,74,Rab protein signal transduction,BP
GO:0043010,0.001506888252645732,0.999284288807666,27,314,camera-type eye development,BP
GO:0004518,0.0015138736094094337,0.9993910320594699,19,199,nuclease activity,MF
GO:0001654,0.0015175830157673196,0.99924716717438955,30,362,eye development,BP
GO:0030133,0.0015214206994039056,0.9992446932667474,30,371,transport vesicle,CC
GO:0042058,0.0015233645308014813,0.9995722378874423,11,86,regulation of epidermal growth factor receptor signaling pathway,BP
GO:0048013,0.0015314067526822077,0.9995696912603447,11,86,ephrin receptor signaling pathway,BP
GO:0032507,0.001531585288525477,0.9996023560141305,10,74,maintenance of protein location in cell,BP
GO:0042110,0.0015415395993559392,0.9991886040455341,35,456,T cell activation,BP
GO:0006790,0.001573372793909801,0.9992171544664882,30,371,sulfur compound metabolic process,BP
GO:0021537,0.0015751429565927567,0.9993012853347977,23,250,telencephalon development,BP
GO:0007183,0.001591927524021827,0.9998782179582069,4,13,SMAD protein complex assembly,BP
GO:0035458,0.0016018650850154717,0.9998168478353724,5,20,cellular response to interferon-beta,BP
GO:1903055,0.0016041611171686986,0.9998148514874332,5,21,positive regulation of extracellular matrix organization,BP
GO:0050661,0.0016166594782109028,0.9996572114648068,8,51,NADP binding,MF
GO:1903555,0.0016245891038482027,0.9994022750606653,16,162,regulation of tumor necrosis factor superfamily cytokine production,BP
GO:0008201,0.0016352045299936157,0.9993774357915005,17,168,heparin binding,MF
GO:0032640,0.0016438931294179226,0.9993944646524782,16,162,tumor necrosis factor production,BP
GO:0071900,0.001648284290076513,0.99910381917211,38,511,regulation of protein serine/threonine kinase activity,BP
GO:0010763,0.0016617687644356815,0.9998713560149233,4,13,positive regulation of fibroblast migration,BP
GO:0009887,0.001663168181852988,0.998929023179858,70,1059,animal organ morphogenesis,BP
GO:0018209,0.0016659790514969458,0.99920260387338,27,321,peptidyl-serine modification,BP
GO:0051897,0.0016824682419512155,0.999356845318252,17,174,positive regulation of protein kinase B signaling,BP
GO:1904674,0.001689194018134842,1,2,2,positive regulation of somatic stem cell population maintenance,BP
GO:0042752,0.0016892241339937172,0.9994554568212131,13,113,regulation of circadian rhythm,BP
GO:0007257,0.0016962358988278747,0.9996876309095235,7,39,activation of JUN kinase activity,BP
GO:0021953,0.0016982488508243848,0.999330414457341,18,179,central nervous system neuron differentiation,BP
GO:0019724,0.001705471148925992,0.9994491411754555,13,115,B cell mediated immunity,BP
GO:0043406,0.0017057268639562339,0.9992378867512003,23,258,positive regulation of MAP kinase activity,BP
GO:0019103,0.0017093180820445233,0.9999398593216611,3,6,pyrimidine nucleotide binding,MF
GO:1900121,0.0017217384609937406,0.9998653983327146,4,13,negative regulation of receptor binding,BP
GO:0004197,0.0017222803149825557,0.9994433280495576,13,114,cysteine-type endopeptidase activity,MF
GO:0051258,0.0017307400131114086,0.9992100382973631,24,281,protein polymerization,BP
GO:0072529,0.0017318217773438368,0.9996798994102324,7,39,pyrimidine-containing compound catabolic process,BP
GO:0061462,0.0017342199424800933,0.9996785044071034,7,40,protein localization to lysosome,BP
GO:0060998,0.0017351831382570984,0.9995421746159231,10,73,regulation of dendritic spine development,BP
GO:0019200,0.0017512326743141324,0.9997937494149822,5,21,carbohydrate kinase activity,MF
GO:0060142,0.0017651424140005295,0.9997299175395872,6,29,regulation of syncytium formation by plasma membrane fusion,BP
GO:0038061,0.0017658026222017915,0.9993208985229941,17,181,NIK/NF-kappaB signaling,BP
GO:0001085,0.0017690358822713575,0.9993447444624423,16,155,RNA polymerase II transcription factor binding,MF
GO:0044448,0.0017740961039560072,0.9992969756528918,18,184,cell cortex part,CC
GO:0061741,0.0017863497645903988,1,2,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP
GO:0060205,0.0017868654651631817,0.9991393517393201,27,338,cytoplasmic vesicle lumen,CC
GO:0000786,0.0017878388411392636,0.999520059618955,10,91,nucleosome,CC
GO:0030501,0.001789784329222903,0.9996672438281385,7,39,positive regulation of bone mineralization,BP
GO:0034774,0.0017929490287990945,0.9991497638494433,26,321,secretory granule lumen,CC
GO:0090288,0.0017940335754389359,0.9993338816802227,16,159,negative regulation of cellular response to growth factor stimulus,BP
GO:0031667,0.001802228902776346,0.9990235824653154,37,498,response to nutrient levels,BP
GO:1901990,0.0018068721296428066,0.9990686100317588,32,438,regulation of mitotic cell cycle phase transition,BP
GO:0030544,0.001822188067724146,0.999657507871164,7,42,Hsp70 protein binding,MF
GO:0045778,0.0018226066587366811,0.9994752773274752,11,89,positive regulation of ossification,BP
GO:2001252,0.0018306174547054299,0.9992946940952341,17,173,positive regulation of chromosome organization,BP
GO:0043130,0.0018339677465145105,0.9995111170423565,10,76,ubiquitin binding,MF
GO:0032731,0.0018365025651455795,0.9996018669430102,8,52,positive regulation of interleukin-1 beta production,BP
GO:0098693,0.0018452711737209733,0.9993996533899466,13,111,regulation of synaptic vesicle cycle,BP
GO:0070059,0.0018731626106629278,0.9995445047359426,9,62,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP
GO:0030176,0.0018733776563813077,0.9993565517892731,14,132,integral component of endoplasmic reticulum membrane,CC
GO:0007611,0.0018757266046242054,0.9991559056370961,23,255,learning or memory,BP
GO:0022409,0.0018906000371235708,0.9991651954183131,22,249,positive regulation of cell-cell adhesion,BP
GO:0002683,0.0018919113305450434,0.9990011554820729,34,454,negative regulation of immune system process,BP
GO:0031265,0.001901606306242612,0.9999305029120049,3,6,CD95 death-inducing signaling complex,CC
GO:0044292,0.0019055426947433716,0.9998467758861462,4,13,dendrite terminus,CC
GO:0050708,0.0019076644119531794,0.9989822359327157,35,467,regulation of protein secretion,BP
GO:0000354,0.0019196825903157833,1,2,2,cis assembly of pre-catalytic spliceosome,BP
GO:0002480,0.0019232369378224033,1,2,2,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent",BP
GO:0031638,0.001923667046575225,0.9995791660524305,8,53,zymogen activation,BP
GO:1900180,0.0019292273493064405,0.9993677514467599,13,116,regulation of protein localization to nucleus,BP
GO:0002428,0.0019316166075403313,1,2,2,antigen processing and presentation of peptide antigen via MHC class Ib,BP
GO:0097110,0.0019460679098533863,0.9995259305259245,9,59,scaffold protein binding,MF
GO:0043021,0.0019586044374948486,0.9993237825917263,14,133,ribonucleoprotein complex binding,MF
GO:0031050,0.0019867775766718335,0.9995645150598624,8,51,dsRNA processing,BP
GO:0070918,0.0019867775766718335,0.9995645150598624,8,51,production of small RNA involved in gene silencing by RNA,BP
GO:0008022,0.0020011186343341595,0.9991976642299186,18,187,protein C-terminus binding,MF
GO:0071383,0.0020013191510138252,0.999112297833961,22,248,cellular response to steroid hormone stimulus,BP
GO:0000978,0.002025811486686396,0.9988673691880701,40,528,RNA polymerase II proximal promoter sequence-specific DNA binding,MF
GO:0070234,0.002054211871280844,0.9998279854187001,4,14,positive regulation of T cell apoptotic process,BP
GO:0030139,0.0020556841207520077,0.9990489115753863,24,284,endocytic vesicle,CC
GO:1990454,0.0020574750772792,0.9998349876951187,4,12,L-type voltage-gated calcium channel complex,CC
GO:0035455,0.002068412533888116,0.9997468249398616,5,21,response to interferon-alpha,BP
GO:0097617,0.002079788194360333,0.999828642496042,4,13,annealing activity,MF
GO:1904814,0.0020814659572360476,0.9998250630036911,4,14,"regulation of protein localization to chromosome, telomeric region",BP
GO:0008252,0.0020838934426237704,0.9998248021770401,4,14,nucleotidase activity,MF
GO:0098609,0.0020856745543174388,0.9987085628593678,57,833,cell-cell adhesion,BP
GO:0002366,0.0020865810574087064,0.9987650231704606,48,702,leukocyte activation involved in immune response,BP
GO:0030016,0.002089660133183,0.999091200305699,21,224,myofibril,CC
GO:0051582,0.0020950283802452035,0.9999207377400295,3,6,positive regulation of neurotransmitter uptake,BP
GO:1902737,0.002116143851852278,1,2,2,dendritic filopodium,CC
GO:0031380,0.002117301466607475,1,2,2,nuclear RNA-directed RNA polymerase complex,CC
GO:0050878,0.002121982181469459,0.9988391529581766,37,497,regulation of body fluid levels,BP
GO:0062023,0.002128498774169287,0.9988928570922329,32,406,collagen-containing extracellular matrix,CC
GO:0040017,0.0021325740486421033,0.9987929939719112,41,595,positive regulation of locomotion,BP
GO:0042089,0.002139159909184407,0.9992886427519629,13,123,cytokine biosynthetic process,BP
GO:0009650,0.0021408402647275526,0.9998221837716277,4,13,UV protection,BP
GO:0008202,0.0021443510312952455,0.9989540635074211,27,331,steroid metabolic process,BP
GO:1901558,0.002159499598082671,1,2,2,response to metformin,BP
GO:0008266,0.0021860246192364876,0.9996492347680984,6,30,poly(U) RNA binding,MF
GO:0060485,0.0021862975809719704,0.9989844162836912,24,276,mesenchyme development,BP
GO:0051056,0.0021957626809078422,0.9989121547936032,28,338,regulation of small GTPase mediated signal transduction,BP
GO:0030426,0.0022191269200198677,0.9991293770226028,17,171,growth cone,CC
GO:0003684,0.0022220343246996867,0.9994438479976785,9,65,damaged DNA binding,MF
GO:0045930,0.002230180650623319,0.9989243345413195,26,333,negative regulation of mitotic cell cycle,BP
GO:0005765,0.0022410121286673334,0.9989030222286964,27,336,lysosomal membrane,CC
GO:0030148,0.0022667486886254794,0.999284239179202,12,102,sphingolipid biosynthetic process,BP
GO:1903305,0.0022681933959466938,0.9991380067084357,16,158,regulation of regulated secretory pathway,BP
GO:1901522,0.0022688256002162187,0.999713974414974,5,22,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP
GO:0140058,0.002285412452078512,0.9997136983345527,5,21,neuron projection arborization,BP
GO:0006163,0.002290991467123012,0.9987183362059777,39,556,purine nucleotide metabolic process,BP
GO:0009147,0.0022933383339149953,0.9997101602509153,5,22,pyrimidine nucleoside triphosphate metabolic process,BP
GO:0045649,0.0022966076495630643,0.9997096508067697,5,22,regulation of macrophage differentiation,BP
GO:0007596,0.00229695642060631,0.9988737845755713,27,334,blood coagulation,BP
GO:0044420,0.00229816335569078,0.999484217511004,8,51,extracellular matrix component,CC
GO:0007178,0.0023099896325929907,0.9988507106425222,28,347,transmembrane receptor protein serine/threonine kinase signaling pathway,BP
GO:0000082,0.0023103456012421087,0.998960414997628,22,272,G1/S transition of mitotic cell cycle,BP
GO:0009163,0.0023107451143629673,0.9995468525785284,7,42,nucleoside biosynthetic process,BP
GO:0030619,0.0023128790874006274,0.9999000665629535,3,7,U1 snRNA binding,MF
GO:0086067,0.0023132746575957076,0.9998082922040302,4,12,AV node cell to bundle of His cell communication,BP
GO:0098852,0.0023156081946185906,0.9988637292683668,27,337,lytic vacuole membrane,CC
GO:0010656,0.0023222087020082403,0.9995344378011778,7,54,negative regulation of muscle cell apoptotic process,BP
GO:0006012,0.0023331445820432154,0.9998014990856924,4,13,galactose metabolic process,BP
GO:1901657,0.0023351693035061436,0.9991428477487699,15,145,glycosyl compound metabolic process,BP
GO:1903313,0.0023412197835141688,0.9993534453219278,10,78,positive regulation of mRNA metabolic process,BP
GO:1902416,0.002350421541835559,0.9998978584212647,3,7,positive regulation of mRNA binding,BP
GO:0042692,0.00235342952702734,0.9988105196589396,29,377,muscle cell differentiation,BP
GO:0045667,0.0023555294256274676,0.9992088014671874,13,120,regulation of osteoblast differentiation,BP
GO:0034399,0.0023602260154054425,0.9991688045795701,14,131,nuclear periphery,CC
GO:0060147,0.0023612668458943215,0.9992468840094143,12,113,regulation of posttranscriptional gene silencing,BP
GO:0060966,0.0023612668458943215,0.9992468840094143,12,113,regulation of gene silencing by RNA,BP
GO:0006637,0.002361484675557442,0.9992494669481801,12,105,acyl-CoA metabolic process,BP
GO:0035383,0.002361484675557442,0.9992494669481801,12,105,thioester metabolic process,BP
GO:0039694,0.002361637138504112,0.999611955165913,6,32,viral RNA genome replication,BP
GO:0007000,0.002363598862259946,0.9998970803090755,3,7,nucleolus organization,BP
GO:0045004,0.0023664059987325656,1,2,2,DNA replication proofreading,BP
GO:0086014,0.0023711294899659186,0.9997030772998184,5,20,atrial cardiac muscle cell action potential,BP
GO:0086026,0.0023711294899659186,0.9997030772998184,5,20,atrial cardiac muscle cell to AV node cell signaling,BP
GO:0086066,0.0023711294899659186,0.9997030772998184,5,20,atrial cardiac muscle cell to AV node cell communication,BP
GO:0042107,0.0023718896581574585,0.9992014926637518,13,124,cytokine metabolic process,BP
GO:0038003,0.002372401176347724,0.9998019966091048,4,12,opioid receptor signaling pathway,BP
GO:0006284,0.002399629996535578,0.9995262189212514,7,42,base-excision repair,BP
GO:0034404,0.0024014977369973176,0.9989654627103457,20,225,nucleobase-containing small molecule biosynthetic process,BP
GO:0006513,0.0024092776144955556,0.9993889920702986,9,66,protein monoubiquitination,BP
GO:0060529,0.0024122567081786253,1,2,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP
GO:0044452,0.0024151103245804496,0.9990434677654395,17,177,nucleolar part,CC
GO:1902186,0.0024151211090757433,0.9996029233618421,6,31,regulation of viral release from host cell,BP
GO:0005215,0.0024152471043629403,0.998405691005702,73,1130,transporter activity,MF
GO:0010755,0.0024189986644343,0.9997879934115614,4,14,regulation of plasminogen activation,BP
GO:0051403,0.002419583031072324,0.998866237523585,24,284,stress-activated MAPK cascade,BP
GO:0032655,0.002420461499309868,0.9994503782221064,8,53,regulation of interleukin-12 production,BP
GO:0051153,0.002452925590831515,0.9992136783473872,12,114,regulation of striated muscle cell differentiation,BP
GO:0002121,0.0024560053449639773,1,2,2,inter-male aggressive behavior,BP
GO:0071541,0.002460150890155715,0.9998913310821691,3,7,"eukaryotic translation initiation factor 3 complex, eIF3m",CC
GO:0019081,0.0024627534042039,0.9997830740418056,4,14,viral translation,BP
GO:0052173,0.002475815933944001,0.9998903904374485,3,7,response to defenses of other organism involved in symbiotic interaction,BP
GO:0052200,0.002475815933944001,0.9998903904374485,3,7,response to host defenses,BP
GO:0075136,0.002475815933944001,0.9998903904374485,3,7,response to host,BP
GO:0010921,0.002482700742628328,0.9990146546173219,17,174,regulation of phosphatase activity,BP
GO:1902806,0.002485975826417652,0.9990092432422724,17,196,regulation of cell cycle G1/S phase transition,BP
GO:0008285,0.0024940043371712408,0.9985090026796647,48,739,negative regulation of cell proliferation,BP
GO:0006914,0.0024989539398375285,0.9986309034638213,36,495,autophagy,BP
GO:0061919,0.0024989539398375285,0.9986309034638213,36,495,process utilizing autophagic mechanism,BP
GO:0035258,0.0025069264559473845,0.9992469380880877,11,91,steroid hormone receptor binding,MF
GO:0051289,0.0025151614207618257,0.9992432407939649,11,93,protein homotetramerization,BP
GO:2000300,0.002531149541933799,0.9992939374259291,10,77,regulation of synaptic vesicle exocytosis,BP
GO:0007173,0.002534461111032736,0.9991417575424684,13,119,epidermal growth factor receptor signaling pathway,BP
GO:0032728,0.002536726901292746,0.9995805288442289,6,30,positive regulation of interferon-beta production,BP
GO:0008631,0.0025680286478723963,0.999485573001034,7,43,intrinsic apoptotic signaling pathway in response to oxidative stress,BP
GO:1903786,0.002570825264521338,1,2,2,regulation of glutathione biosynthetic process,BP
GO:0045653,0.0025710137557437163,0.999760939218153,4,17,negative regulation of megakaryocyte differentiation,BP
GO:0060090,0.0025805369254644304,0.9988554367259974,21,237,molecular adaptor activity,MF
GO:0018105,0.002585675402977069,0.9987610508405618,25,298,peptidyl-serine phosphorylation,BP
GO:0031428,0.0025970079464916565,0.9998830403726252,3,7,box C/D snoRNP complex,CC
GO:0045807,0.0026177777661751636,0.9990256162662879,15,152,positive regulation of endocytosis,BP
GO:0006643,0.0026193238902436937,0.9988919813294488,19,206,membrane lipid metabolic process,BP
GO:0006811,0.0026314277976014423,0.9981450522147459,101,1676,ion transport,BP
GO:0032570,0.0026680702301159973,0.9994606768854905,7,44,response to progesterone,BP
GO:0008203,0.002672451378368224,0.9990035934527526,15,150,cholesterol metabolic process,BP
GO:0006925,0.0026754234703046604,0.9996494874622935,5,22,inflammatory cell apoptotic process,BP
GO:0045637,0.0026822611845135767,0.9988048210202874,21,248,regulation of myeloid cell differentiation,BP
GO:0071425,0.002696975297523189,0.9996434577155753,5,23,hematopoietic stem cell proliferation,BP
GO:0002791,0.0026998442152664512,0.9985137744810403,36,495,regulation of peptide secretion,BP
GO:0003401,0.002703540498805787,0.9995452197865727,6,31,axis elongation,BP
GO:0051651,0.0027038660461193957,0.9991787419156338,11,93,maintenance of location in cell,BP
GO:0098910,0.0027082702104617596,0.999876181186713,3,7,regulation of atrial cardiac muscle cell action potential,BP
GO:0061900,0.002710191087561594,0.9993703649651783,8,56,glial cell activation,BP
GO:0005262,0.0027134913189509604,0.9990322531829522,14,123,calcium channel activity,MF
GO:0006260,0.002732459676401836,0.9987301797225537,23,274,DNA replication,BP
GO:0097300,0.0027352322072850465,0.999441368662133,7,47,programmed necrotic cell death,BP
GO:0035303,0.002736913465000887,0.998837232361439,19,208,regulation of dephosphorylation,BP
GO:0032147,0.002753665654542107,0.9986319413310808,27,333,activation of protein kinase activity,BP
GO:0008015,0.002763129178803325,0.9984380612054177,39,536,blood circulation,BP
GO:0071353,0.0027694842450876325,0.9995300135547794,6,32,cellular response to interleukin-4,BP
GO:0061133,0.002780171047952748,0.9998716931879971,3,7,endopeptidase activator activity,MF
GO:0051301,0.00278603046936292,0.9983881779400093,42,597,cell division,BP
GO:0002790,0.002788922579915228,0.9983750515695499,43,619,peptide secretion,BP
GO:0031668,0.0027931330572766883,0.9987004445380889,23,268,cellular response to extracellular stimulus,BP
GO:0034775,0.002796356996698628,1,2,2,glutathione transmembrane transport,BP
GO:0035443,0.002796356996698628,1,2,2,tripeptide transmembrane transport,BP
GO:0003712,0.002826563837214471,0.99838730183534,40,560,transcription coregulator activity,MF
GO:0007599,0.002827302700841667,0.9985920358111902,27,339,hemostasis,BP
GO:0005114,0.002829895159938369,0.9998685644365108,3,7,type II transforming growth factor beta receptor binding,MF
GO:1901184,0.0028306388605342722,0.9991350607760197,11,93,regulation of ERBB signaling pathway,BP
GO:0022612,0.00283740700088568,0.9990267938595067,13,118,gland morphogenesis,BP
GO:0046339,0.0028416334510519827,0.9996224159916773,5,22,diacylglycerol metabolic process,BP
GO:0030695,0.0028741374120064777,0.9986109842685317,25,303,GTPase regulator activity,MF
GO:0002756,0.0028896748095314497,0.9995035686857477,6,33,MyD88-independent toll-like receptor signaling pathway,BP
GO:0016235,0.0028904777657591733,0.999408464063787,7,43,aggresome,CC
GO:0060340,0.002899628569947749,0.9997377845798384,4,13,positive regulation of type I interferon-mediated signaling pathway,BP
GO:0030278,0.002909876553093916,0.9987896616420817,18,196,regulation of ossification,BP
GO:0002221,0.0029235693372471018,0.9987832233838427,18,197,pattern recognition receptor signaling pathway,BP
GO:0022624,0.0029252965554946012,0.9996032932506124,5,24,proteasome accessory complex,CC
GO:0002064,0.002933770753896549,0.9987464281680958,19,204,epithelial cell development,BP
GO:0016125,0.0029728838891360763,0.9988365371114584,16,166,sterol metabolic process,BP
GO:1900407,0.0029750370500028823,0.9991451075993619,10,87,regulation of cellular response to oxidative stress,BP
GO:0099173,0.002979510271442911,0.9988347207275806,16,162,postsynapse organization,BP
GO:0006333,0.003006603751719514,0.9988197965999162,16,175,chromatin assembly or disassembly,BP
GO:0005802,0.00300913136798141,0.9986776207682229,20,225,trans-Golgi network,CC
GO:0071260,0.0030266081461462957,0.9991329656822312,10,79,cellular response to mechanical stimulus,BP
GO:0043408,0.0030396776805881104,0.9981354051739162,51,762,regulation of MAPK cascade,BP
GO:0045766,0.0030534678023255435,0.9987575602928822,17,200,positive regulation of angiogenesis,BP
GO:0070841,0.0030713644055309548,0.9995813944118337,5,23,inclusion body assembly,BP
GO:0048708,0.0030811622421147043,0.999114450602813,10,80,astrocyte differentiation,BP
GO:0060028,0.0030902794197595314,0.9998518553743326,3,7,convergent extension involved in axis elongation,BP
GO:0015085,0.0031005492375072775,0.9988291279392936,15,139,calcium ion transmembrane transporter activity,MF
GO:0030427,0.0031018410053248514,0.998741208815978,17,176,site of polarized growth,CC
GO:0110053,0.003105108647063647,0.9985700605373529,22,258,regulation of actin filament organization,BP
GO:1903039,0.0031129884419572734,0.9986609559330275,19,212,positive regulation of leukocyte cell-cell adhesion,BP
GO:0019787,0.0031462348841917757,0.9983377128118753,31,407,ubiquitin-like protein transferase activity,MF
GO:0032615,0.0031504498194399695,0.9992507876631452,8,55,interleukin-12 production,BP
GO:0005096,0.0031662571474979726,0.9985111195766074,23,272,GTPase activator activity,MF
GO:0098876,0.003175049679832964,0.9990134140671215,11,96,vesicle-mediated transport to the plasma membrane,BP
GO:0046835,0.003178234344578714,0.9995605157601956,5,24,carbohydrate phosphorylation,BP
GO:0033688,0.0031803920474519514,0.9995629626392081,5,23,regulation of osteoblast proliferation,BP
GO:0060603,0.0031811639911704034,0.9994426756192506,6,33,mammary gland duct morphogenesis,BP
GO:0070199,0.0031943950069116293,0.9995577537436932,5,24,establishment of protein localization to chromosome,BP
GO:0098642,0.0032051670950405927,0.999844314228284,3,7,network-forming collagen trimer,CC
GO:0098645,0.0032051670950405927,0.999844314228284,3,7,collagen network,CC
GO:0007423,0.0032066701077237115,0.9981575868943735,40,546,sensory organ development,BP
GO:2001171,0.0032075266705338668,0.9994352148298072,6,34,positive regulation of ATP biosynthetic process,BP
GO:0035497,0.0032119518136230064,0.9996951665538591,4,14,cAMP response element binding,MF
GO:0051222,0.0032219026808755005,0.9982944581747581,31,413,positive regulation of protein transport,BP
GO:0016528,0.0032252485346427016,0.9990670508554932,10,80,sarcoplasm,CC
GO:2000060,0.003228308181374302,0.9989952046934453,11,95,positive regulation of ubiquitin-dependent protein catabolic process,BP
GO:0003678,0.0032285319184493996,0.9990659670262317,10,80,DNA helicase activity,MF
GO:1901655,0.003237822407772719,0.998992980803011,11,93,cellular response to ketone,BP
GO:1901988,0.0032386393604175983,0.9985309932195695,21,263,negative regulation of cell cycle phase transition,BP
GO:0002455,0.003246565769363796,0.9993172740791416,7,46,humoral immune response mediated by circulating immunoglobulin,BP
GO:0031227,0.0032515277138096326,0.9988100437025658,14,140,intrinsic component of endoplasmic reticulum membrane,CC
GO:0014902,0.0032621654664549537,0.9989190457427781,12,109,myotube differentiation,BP
GO:0098797,0.003269340188865047,0.9981193154881159,40,548,plasma membrane protein complex,CC
GO:0008380,0.003272031924105641,0.998246404723208,32,435,RNA splicing,BP
GO:0097441,0.0033037441535493,0.999837763825988,3,7,basal dendrite,CC
GO:0000781,0.0033278786416109604,0.9987276192322896,15,157,"chromosome, telomeric region",CC
GO:0008287,0.003333599197111647,0.9992969386621688,7,45,protein serine/threonine phosphatase complex,CC
GO:1903293,0.003333599197111647,0.9992969386621688,7,45,phosphatase complex,CC
GO:0014074,0.003334439799909517,0.9987276827701683,15,148,response to purine-containing compound,BP
GO:0017148,0.0033422413597152026,0.9987125348119859,15,195,negative regulation of translation,BP
GO:0070227,0.0033485257287268625,0.999104877648945,9,69,lymphocyte apoptotic process,BP
GO:0009593,0.9999997474286604,1.5625113769528117e-6,4,488,detection of chemical stimulus,BP
GO:0004930,0.999999885744892,3.821523558211755e-7,13,840,G protein-coupled receptor activity,MF
GO:0050907,0.9999999885761166,1.3206153858502639e-7,2,454,detection of chemical stimulus involved in sensory perception,BP
GO:0004984,0.9999999947666867,1.0823934609376717e-7,1,404,olfactory receptor activity,MF
GO:0050911,0.9999999947666867,1.0823934609376717e-7,1,404,detection of chemical stimulus involved in sensory perception of smell,BP
